data_1zec_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zec _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 122.642 1.21 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.5 t -58.9 -29.61 41.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.537 -2.574 . . . . 0.0 109.171 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.8 mt -89.03 -20.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.993 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.441 ' O ' HG11 ' A' ' 15' ' ' VAL . . . -92.59 -34.5 6.94 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 117.969 -2.062 . . . . 0.0 110.179 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.577 ' CE3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.19 -56.43 20.19 Favored Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.462 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.5 Cg_endo -40.49 -40.49 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.008 2.472 . . . . 0.0 108.819 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.45 61.53 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 118.586 -1.246 . . . . 0.0 109.129 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.577 HG23 ' CE3' ' A' ' 12' ' ' TRP . 5.2 m -64.72 -52.18 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -47.78 84.24 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.44 -5.0 6.53 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 117.572 -1.651 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HG2' HH11 ' A' ' 18' ' ' ARG . 69.3 ttt-85 -100.63 -56.1 2.42 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mmm -54.66 -39.49 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.335 -1.302 . . . . 0.0 114.206 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -48.24 -62.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -40.54 -64.25 0.54 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.485 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.75 -46.16 20.24 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -146.44 74.82 12.62 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.499 1.798 0 C-N-CA 125.036 3.824 . . . . 0.0 113.361 -169.345 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 N--CA 1.502 2.129 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 p -64.34 -26.93 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 122.312 1.054 . . . . 0.0 108.239 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -82.2 -13.5 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.342 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.06 -28.37 10.0 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.522 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.631 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -57.95 -56.98 29.16 Favored Pre-proline 0 N--CA 1.505 2.288 0 C-N-CA 117.726 -1.589 . . . . 0.0 108.457 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.463 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.4 Cg_endo -38.79 -52.85 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 123.638 2.892 . . . . 0.0 108.187 170.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.44 -41.94 77.3 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 122.873 1.321 . . . . 0.0 112.055 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.631 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -64.39 -50.21 77.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 112.269 -2.241 . . . . 0.0 109.828 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -64.75 -34.33 78.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.6 -6.91 47.43 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 112.265 -2.243 . . . . 0.0 110.546 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 16.1 tpt180 -101.01 -48.69 4.35 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.75 -48.47 81.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.857 -1.52 . . . . 0.0 114.142 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -48.3 -50.75 28.89 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 79.1 ttt180 -54.24 -71.77 0.07 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 112.891 -1.958 . . . . 0.0 112.968 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.77 -41.18 43.63 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -148.43 81.54 7.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.574 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 C--N 1.31 -1.487 0 C-N-CA 123.463 2.775 . . . . 0.0 112.379 174.86 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 123.23 1.491 . . . . 0.0 108.502 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.3 t -51.78 -37.13 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 110.811 -2.904 . . . . 0.0 112.958 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.85 -18.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.232 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -88.69 -37.5 7.39 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 117.57 -2.252 . . . . 0.0 109.586 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.546 ' CE3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -49.82 -57.82 11.21 Favored Pre-proline 0 N--CA 1.502 2.149 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.465 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -44.91 -27.42 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.154 1.903 . . . . 0.0 110.651 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.17 -32.98 17.21 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.546 HG21 ' CE3' ' A' ' 12' ' ' TRP . 10.3 m -69.95 -54.17 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.083 0.944 . . . . 0.0 110.175 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -64.81 -7.74 12.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 113.323 -1.762 . . . . 0.0 112.239 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -100.65 -49.36 4.21 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.5 mmm -57.54 -38.25 74.44 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.701 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -54.83 -61.83 2.05 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -34.88 -60.03 0.46 Allowed 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.928 1.393 . . . . 0.0 113.111 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.1 -74.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 112.692 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -116.16 72.56 4.77 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.523 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 N--CA 1.503 2.057 1 C-N-CA 125.491 4.127 . . . . 0.0 113.491 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 124.154 1.931 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 t -63.14 -28.33 44.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 110.046 -3.252 . . . . 0.0 109.468 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.2 mt -91.23 -23.55 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.874 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.5 -36.36 9.67 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 117.879 -2.105 . . . . 0.0 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.4 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -49.47 -59.37 6.76 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.073 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 12' ' ' TRP . 18.5 Cg_endo -43.34 -28.3 1.51 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.269 2.646 . . . . 0.0 111.604 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.29 -49.62 12.16 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 124.203 1.954 . . . . 0.0 107.204 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.53 -51.16 60.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.735 -2.938 . . . . 0.0 110.473 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -61.37 -37.71 84.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.94 -15.39 59.05 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 117.393 -1.723 . . . . 0.0 112.355 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.44 -54.06 2.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.0 mmm -54.59 -32.59 58.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.547 -2.115 . . . . 0.0 114.255 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -51.59 -62.13 1.82 Allowed 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -40.47 -61.57 0.9 Allowed 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.753 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.95 -62.93 1.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -131.89 75.56 75.49 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.499 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.499 1.818 0 C-N-CA 124.819 3.679 . . . . 0.0 113.408 -176.876 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 124.034 1.873 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.97 -29.92 32.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 109.653 -3.43 . . . . 0.0 112.055 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.89 -24.64 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.25 -28.48 14.87 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 118.475 -1.822 . . . . 0.0 111.604 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.614 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.4 -59.15 12.91 Favored Pre-proline 0 N--CA 1.495 1.785 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.02 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.3 Cg_endo -41.9 -43.19 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.725 2.283 . . . . 0.0 109.351 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.76 92.64 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 123.068 1.413 . . . . 0.0 110.281 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.614 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -66.24 -51.88 54.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.612 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -64.99 -32.97 74.96 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -67.72 -15.64 63.74 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.012 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HB2' ' NH2' ' A' ' 18' ' ' ARG . 35.8 ttm105 -100.06 -39.1 8.28 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.479 1.133 . . . . 0.0 109.004 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.4 mtp -69.14 -50.14 50.52 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.014 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -55.51 -51.01 68.43 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -49.71 -68.03 0.21 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.178 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.19 63.19 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -149.33 83.03 6.68 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 C--N 1.312 -1.352 0 C-N-CA 124.111 3.207 . . . . 0.0 111.991 174.023 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.505 2.277 0 CA-C-O 123.973 1.844 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.26 -25.85 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 111.327 -2.67 . . . . 0.0 113.813 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 42.1 mt -93.0 -35.16 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 122.566 1.174 . . . . 0.0 110.042 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -38.74 66.72 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 118.309 -1.9 . . . . 0.0 110.233 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.533 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -54.61 -61.44 5.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 117.629 -1.628 . . . . 0.0 112.902 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.432 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 25.7 Cg_endo -47.98 -20.6 2.17 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.659 1.573 . . . . 0.0 110.337 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 -32.44 16.64 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 123.843 1.782 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -73.41 -49.25 38.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 112.063 -2.335 . . . . 0.0 108.637 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -61.92 -37.46 84.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -63.94 -17.37 63.18 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 110.963 -2.835 . . . . 0.0 110.664 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.9 ttm180 -101.2 -41.91 6.54 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.503 1.62 . . . . 0.0 109.669 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 63.4 mtp -63.66 -34.8 78.66 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.682 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -56.36 -63.59 1.14 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 12.2 tpt180 -36.68 -61.57 0.53 Allowed 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.504 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.85 -60.77 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -137.75 72.87 48.34 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.107 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.502 1.989 0 C-N-CA 125.003 3.802 . . . . 0.0 113.852 -170.331 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 123.897 1.808 . . . . 0.0 106.733 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.03 -28.32 40.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 110.841 -2.891 . . . . 0.0 111.385 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.4 mt -93.06 -21.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.8 -29.99 10.08 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 118.688 -1.72 . . . . 0.0 110.629 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.632 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -53.59 -57.12 18.63 Favored Pre-proline 0 N--CA 1.496 1.855 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.115 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.463 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.0 Cg_endo -41.03 -43.0 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 123.475 2.784 . . . . 0.0 110.097 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.22 94.5 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 123.494 1.616 . . . . 0.0 108.276 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.632 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -62.01 -48.18 89.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 111.382 -2.645 . . . . 0.0 110.283 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.412 ' N ' HG11 ' A' ' 15' ' ' VAL . 23.9 ttp85 -64.27 -34.77 78.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -75.33 -6.18 48.61 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 14.3 ttm180 -100.71 -40.02 7.56 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 123.867 1.794 . . . . 0.0 107.877 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 70.9 mtp -65.82 -46.64 77.84 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.572 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -50.13 -59.23 4.13 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -43.67 -63.31 0.87 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.486 178.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.18 -43.71 42.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -153.28 81.58 5.01 Favored Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.725 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo . . . . . 0 N--CA 1.493 1.496 0 C-N-CA 124.58 3.52 . . . . 0.0 115.29 -174.419 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.602 0.715 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.7 t -48.33 -34.78 5.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.312 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.6 mt -91.25 -22.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.039 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.3 -21.04 25.87 Favored Glycine 0 N--CA 1.505 3.278 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -57.15 17.95 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -40.75 -43.49 4.51 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.641 2.227 . . . . 0.0 109.281 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.74 72.42 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 123.748 1.737 . . . . 0.0 108.902 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.437 ' O ' ' SD ' ' A' ' 19' ' ' MET . 6.3 t -56.84 -60.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 110.117 -3.219 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -61.35 -29.01 69.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 116.578 -2.049 . . . . 0.0 109.777 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.93 -12.66 60.41 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 115.792 -2.363 . . . . 0.0 111.187 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.479 ' HB3' ' SD ' ' A' ' 19' ' ' MET . 44.7 ttm180 -101.56 -47.06 4.77 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 123.716 1.722 . . . . 0.0 108.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -62.26 -40.24 95.54 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.932 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -54.32 -63.61 1.1 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -36.19 -62.47 0.44 Allowed 'General case' 0 N--CA 1.512 2.652 0 O-C-N 123.765 0.666 . . . . 0.0 112.052 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.06 -39.21 41.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.11 83.36 3.82 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo . . . . . 0 N--CA 1.495 1.602 0 C-N-CA 123.7 2.933 . . . . 0.0 108.496 172.749 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 124.063 1.887 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.17 -18.21 23.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 110.374 -3.103 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.403 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 35.6 mm -91.76 -36.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.594 1.187 . . . . 0.0 110.731 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.19 -26.92 42.15 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.904 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.601 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.4 -59.8 12.69 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 117.91 -1.516 . . . . 0.0 110.457 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.474 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -42.45 -42.59 8.05 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.66 2.24 . . . . 0.0 108.885 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -44.97 95.05 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 123.876 1.798 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.601 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -60.27 -55.68 22.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 111.013 -2.812 . . . . 0.0 109.447 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.441 ' N ' HG11 ' A' ' 15' ' ' VAL . 3.2 ttp180 -65.97 -30.65 71.25 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 116.659 -2.017 . . . . 0.0 107.166 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.89 -13.5 62.21 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.171 -1.811 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -100.76 -49.85 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -59.18 -38.55 80.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.659 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -51.06 -62.96 1.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -38.05 -64.61 0.39 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.392 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.91 -60.77 2.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.14 76.02 70.19 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.672 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo . . . . . 0 N--CA 1.496 1.641 0 C-N-CA 124.62 3.547 . . . . 0.0 114.259 -175.588 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.05 -27.42 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.705 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.25 -14.86 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.578 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.434 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -91.38 -39.2 5.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.014 -2.041 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.54 ' CE3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -50.61 -57.41 13.35 Favored Pre-proline 0 N--CA 1.51 2.568 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.495 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.7 Cg_endo -41.21 -41.75 4.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.303 2.002 . . . . 0.0 108.335 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.75 -34.86 62.58 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.267 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.54 HG23 ' CE3' ' A' ' 12' ' ' TRP . 13.3 m -64.23 -48.2 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -62.81 -49.76 73.68 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -59.06 -12.45 4.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 112.029 -2.351 . . . . 0.0 110.689 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -99.64 -44.69 6.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 67.2 mmm -57.26 -26.33 60.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -58.75 -64.12 1.04 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -34.93 -60.4 0.45 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 124.319 1.012 . . . . 0.0 111.787 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.27 -64.51 0.79 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.36 69.38 68.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 124.534 1.147 . . . . 0.0 113.762 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.504 2.089 1 C-N-CA 125.421 4.081 . . . . 0.0 113.37 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 122.954 1.359 . . . . 0.0 108.251 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.12 -25.59 36.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 111.206 -2.724 . . . . 0.0 108.745 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.408 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 69.7 mt -90.5 -30.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.817 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.02 -29.7 27.77 Favored Glycine 0 N--CA 1.502 3.044 0 C-N-CA 118.047 -2.025 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.622 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.74 -59.09 13.41 Favored Pre-proline 0 N--CA 1.494 1.754 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 12' ' ' TRP . 15.0 Cg_endo -43.19 -36.41 5.95 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.735 2.29 . . . . 0.0 109.863 174.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.5 63.77 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 123.673 1.702 . . . . 0.0 109.143 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.622 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -60.05 -48.83 86.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.603 -2.544 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -66.32 -35.86 81.45 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.93 -12.42 61.61 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.342 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -100.73 -41.76 6.77 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.107 1.432 . . . . 0.0 109.085 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.8 mtp -63.5 -39.01 93.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.692 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -53.75 -62.35 1.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -39.62 -65.32 0.4 Allowed 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.741 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.54 47.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -155.16 84.93 3.56 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 124.284 0.99 . . . . 0.0 109.356 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.493 1.467 0 C-N-CA 124.255 3.303 . . . . 0.0 110.568 -178.73 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.509 2.495 0 CA-C-O 124.007 1.86 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.25 -26.81 3.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 110.852 -2.885 . . . . 0.0 113.158 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 mt -94.53 -18.78 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.052 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.74 -36.22 6.53 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.44 -58.56 7.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 114.178 -1.011 . . . . 0.0 109.879 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -41.88 -35.48 3.01 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.626 2.884 . . . . 0.0 110.539 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.23 58.69 Favored 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 123.886 1.803 . . . . 0.0 109.453 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.32 -51.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 110.366 -3.106 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -60.31 -37.52 80.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.8 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -71.07 -6.98 43.27 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.186 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.03 -62.77 1.2 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mmm -45.67 -35.23 3.99 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.818 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -50.75 -50.09 56.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -55.68 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.571 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.01 83.83 3.78 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.421 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo . . . . . 0 N--CA 1.497 1.699 0 C-N-CA 124.628 3.552 . . . . 0.0 113.813 -178.268 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 122.573 1.177 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.76 -28.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 111.936 -2.393 . . . . 0.0 107.875 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.9 -18.93 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.407 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -95.1 -34.46 6.15 Favored Glycine 0 N--CA 1.5 2.966 0 C-N-CA 118.011 -2.042 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.579 ' CE3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.36 -54.65 36.39 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.444 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -40.42 -46.24 4.4 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.268 1.979 . . . . 0.0 108.715 171.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.54 73.38 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.518 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.579 HG23 ' CE3' ' A' ' 12' ' ' TRP . 4.9 m -65.64 -51.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -55.96 -49.19 74.25 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.606 1.193 . . . . 0.0 107.829 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.54 -11.89 2.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 111.883 -2.417 . . . . 0.0 111.446 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -101.3 -51.28 3.53 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.1 mtp -53.17 -45.91 68.7 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.827 -1.533 . . . . 0.0 114.102 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -46.89 -59.15 3.27 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -41.92 -67.13 0.28 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.346 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -36.64 -51.87 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.131 0.972 . . . . 0.0 112.857 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.43 83.41 3.69 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 124.801 1.313 . . . . 0.0 112.646 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo . . . . . 0 N--CA 1.497 1.734 0 C-N-CA 124.576 3.517 . . . . 0.0 113.089 -174.149 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.71 -31.03 28.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.242 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -94.97 -12.0 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.222 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.61 -36.3 5.64 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.069 -2.015 . . . . 0.0 110.075 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.529 ' CE3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.37 -56.23 22.22 Favored Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.478 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.8 Cg_endo -40.66 -39.79 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.202 1.935 . . . . 0.0 108.894 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.53 -36.34 44.96 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.243 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.529 HG21 ' CE3' ' A' ' 12' ' ' TRP . 22.1 m -61.99 -41.74 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -69.57 -50.46 44.52 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -61.49 -11.53 11.18 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.895 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 54.0 ttp180 -100.38 -38.81 8.28 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.984 1.373 . . . . 0.0 108.549 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.9 mmt -70.6 -39.93 73.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.318 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -59.68 -57.48 12.74 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 22.4 ttt-85 -41.48 -63.59 0.68 Allowed 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.645 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.72 64.82 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.6 78.36 10.93 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 124.454 1.096 . . . . 0.0 112.834 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 C--N 1.311 -1.436 0 C-N-CA 123.593 2.862 . . . . 0.0 113.276 -176.959 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.41 -22.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 124.368 1.043 . . . . 0.0 111.745 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.23 -14.29 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.75 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -92.31 -36.43 6.25 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 118.591 -1.766 . . . . 0.0 109.719 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.53 ' CE3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.65 -55.9 25.75 Favored Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 18.3 Cg_endo -43.99 -24.47 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.379 2.719 . . . . 0.0 111.335 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.76 -38.96 12.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.53 HG21 ' CE3' ' A' ' 12' ' ' TRP . 8.8 m -64.21 -49.4 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -61.18 -44.9 96.57 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -12.04 23.7 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.394 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 30.8 ttt85 -101.19 -47.87 4.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 124.142 1.925 . . . . 0.0 107.53 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.3 mmt -63.94 -40.21 95.93 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.153 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -56.87 -59.16 5.44 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 41.0 tpt85 -37.83 -59.21 0.84 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.265 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.31 -55.1 20.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.28 72.55 81.86 Favored Pre-proline 0 N--CA 1.493 1.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.773 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 5.0 Cg_endo . . . . . 0 N--CA 1.498 1.74 0 C-N-CA 125.105 3.87 . . . . 0.0 111.742 -173.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 122.683 1.23 . . . . 0.0 113.267 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.93 -25.28 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 112.311 -2.222 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mt -90.51 -13.31 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.564 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -97.42 -37.36 4.57 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.707 -1.711 . . . . 0.0 109.477 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.574 ' CE3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -48.0 -54.6 23.05 Favored Pre-proline 0 N--CA 1.513 2.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.459 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.7 Cg_endo -39.71 -49.21 3.44 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.784 2.323 . . . . 0.0 108.823 172.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.83 -37.49 84.6 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.855 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.574 HG23 ' CE3' ' A' ' 12' ' ' TRP . 4.0 m -63.4 -52.46 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -56.51 -49.46 74.68 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.578 1.18 . . . . 0.0 108.493 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -15.27 10.33 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ttm105 -101.62 -41.41 6.59 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.094 0.949 . . . . 0.0 109.011 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 78.1 mtp -56.18 -41.08 74.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.268 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.6 ttt-85 -48.68 -69.31 0.12 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -32.46 -59.29 0.32 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 114.713 -1.131 . . . . 0.0 113.11 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.36 19.29 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.816 0.847 . . . . 0.0 112.918 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -141.32 83.05 13.91 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.311 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 N--CA 1.497 1.696 0 C-N-CA 124.36 3.373 . . . . 0.0 115.126 -175.676 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 122.845 1.307 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.52 -33.15 50.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.962 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.427 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 76.3 mt -90.89 -31.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.627 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.63 -34.52 43.83 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.258 -1.925 . . . . 0.0 110.985 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.519 ' CE3' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.32 -59.59 10.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 21.6 Cg_endo -47.21 -22.84 2.58 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.022 1.815 . . . . 0.0 109.891 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.48 -37.1 14.14 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.874 -1.13 . . . . 0.0 108.783 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG13 ' CE3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -66.12 -47.79 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.444 -179.483 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.404 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 45.3 ttt180 -64.0 -38.94 92.92 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.48 -2.62 17.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 111.707 -2.497 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -101.0 -64.5 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 101.709 -3.441 . . . . 0.0 101.709 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 34.3 mtm -47.28 -37.66 11.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.387 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.3 -56.67 11.79 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -42.94 -64.58 0.6 Allowed 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.153 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.62 -42.84 25.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.768 1.227 . . . . 0.0 113.096 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -152.65 84.49 4.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.892 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.312 -1.359 0 C-N-CA 124.083 3.188 . . . . 0.0 111.471 174.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 120.241 0.067 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.23 -32.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 125.62 1.825 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.422 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 71.3 mt -89.24 -22.51 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.433 ' O ' HG11 ' A' ' 15' ' ' VAL . . . -87.34 -37.87 8.01 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 116.96 -2.543 . . . . 0.0 109.643 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.569 ' CE3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -47.02 -57.38 9.32 Favored Pre-proline 0 N--CA 1.513 2.682 0 O-C-N 123.816 0.362 . . . . 0.0 110.64 -179.453 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.2 Cg_endo -40.68 -44.48 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.67 2.246 . . . . 0.0 108.435 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.34 74.07 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.805 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.569 HG23 ' CE3' ' A' ' 12' ' ' TRP . 5.9 m -63.54 -53.78 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.6 ttp85 -59.02 -45.05 91.68 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.89 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.67 -11.16 15.45 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.039 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 -100.86 -50.96 3.68 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.6 mmt -58.78 -39.53 81.34 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -53.42 -56.23 18.54 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 103.522 -2.769 . . . . 0.0 103.522 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -44.69 -65.99 0.45 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.982 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.69 -68.05 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.24 82.67 61.96 Favored Pre-proline 0 N--CA 1.493 1.697 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.194 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 N--CA 1.495 1.587 0 C-N-CA 124.56 3.507 . . . . 0.0 113.14 173.919 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 123.089 1.423 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.36 -28.37 39.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.992 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.1 mt -90.09 -23.85 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.862 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.77 -27.46 12.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.588 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.605 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.96 -58.35 18.27 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.8 Cg_endo -38.91 -48.22 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.773 2.315 . . . . 0.0 108.632 172.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.08 93.32 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.394 1.092 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.605 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -66.32 -46.41 87.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.527 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -67.24 -36.62 82.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -7.45 50.47 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.057 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -101.5 -45.83 5.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 124.041 1.877 . . . . 0.0 106.731 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 42.2 mtm -66.27 -40.59 90.23 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 112.215 -2.266 . . . . 0.0 110.955 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -57.33 -51.66 68.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -48.4 -68.49 0.18 Allowed 'General case' 0 N--CA 1.513 2.723 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.18 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.49 -45.09 12.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.06 85.3 4.3 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.638 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 N--CA 1.498 1.78 0 C-N-CA 124.54 3.493 . . . . 0.0 111.906 179.601 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 123.95 1.833 . . . . 0.0 107.304 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.76 -32.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 110.877 -2.874 . . . . 0.0 113.426 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.0 mt -90.85 -25.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.657 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.23 -30.33 19.98 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.461 -1.828 . . . . 0.0 110.893 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.585 ' CE3' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.95 -59.19 12.34 Favored Pre-proline 0 N--CA 1.496 1.838 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.583 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.479 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 19.1 Cg_endo -43.95 -42.57 12.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.938 2.426 . . . . 0.0 108.959 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.31 -44.18 97.09 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 124.0 1.857 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.585 HG13 ' CE3' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -59.05 -55.84 20.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 110.583 -3.008 . . . . 0.0 109.687 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.484 ' N ' HG13 ' A' ' 15' ' ' VAL . 52.7 ttt180 -63.6 -34.07 77.01 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.142 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.37 -8.69 56.31 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.654 -2.066 . . . . 0.0 111.081 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -101.2 -52.48 3.25 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -57.61 -44.15 85.25 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.818 -1.537 . . . . 0.0 113.704 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -49.1 -48.05 44.7 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -58.1 -75.54 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.372 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.59 -46.33 1.77 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.556 0.693 . . . . 0.0 112.79 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.28 91.04 4.55 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.941 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 N--CA 1.497 1.715 0 C-N-CA 123.102 2.535 . . . . 0.0 109.95 173.211 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 116.48 41.76 0.72 Allowed Glycine 0 N--CA 1.5 2.951 0 O-C-N 124.056 0.847 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.06 129.75 2.82 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.59 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -79.33 49.06 0.94 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.596 0.712 . . . . 0.0 110.104 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.449 ' C ' ' H ' ' A' ' 6' ' ' LYS . 5.7 m95 -125.12 -77.22 0.59 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -66.78 1.14 1.96 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 4' ' ' TRP . 53.4 tttp -31.6 -65.31 0.14 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.846 1.341 . . . . 0.0 111.641 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -50.44 -40.98 51.93 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 122.248 1.023 . . . . 0.0 112.737 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.7 m -67.44 -43.0 82.23 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.642 1.21 . . . . 0.0 109.313 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.5 t -58.9 -29.61 41.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.537 -2.574 . . . . 0.0 109.171 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.8 mt -89.03 -20.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.993 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' O ' HG11 ' A' ' 15' ' ' VAL . . . -92.59 -34.5 6.94 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 117.969 -2.062 . . . . 0.0 110.179 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.577 ' CE3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.19 -56.43 20.19 Favored Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.5 Cg_endo -40.49 -40.49 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.008 2.472 . . . . 0.0 108.819 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.45 61.53 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 118.586 -1.246 . . . . 0.0 109.129 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.577 HG23 ' CE3' ' A' ' 12' ' ' TRP . 5.2 m -64.72 -52.18 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -47.78 84.24 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.44 -5.0 6.53 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 117.572 -1.651 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.417 ' HG2' HH11 ' A' ' 18' ' ' ARG . 69.3 ttt-85 -100.63 -56.1 2.42 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mmm -54.66 -39.49 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.335 -1.302 . . . . 0.0 114.206 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -48.24 -62.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -40.54 -64.25 0.54 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.485 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.75 -46.16 20.24 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -146.44 74.82 12.62 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.56 25.42 0.36 Allowed 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 125.036 3.824 . . . . 0.0 113.361 -169.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.16 -21.78 45.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.31 1.052 . . . . 0.0 109.439 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.642 0 O-C-N 119.483 -2.011 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -163.49 -90.24 0.08 OUTLIER Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.75 153.67 24.57 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -69.05 45.31 0.05 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.52 ' C ' ' H ' ' A' ' 6' ' ' LYS . 77.1 t-105 -161.04 -68.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 104.138 -2.542 . . . . 0.0 104.138 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.0 m -72.94 31.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.479 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 4' ' ' TRP . 57.3 pttt -100.73 -36.68 9.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 p -93.69 -75.6 0.5 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.364 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m -50.06 -19.73 0.8 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 p -64.34 -26.93 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 122.312 1.054 . . . . 0.0 108.239 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -82.2 -13.5 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.342 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.06 -28.37 10.0 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.522 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.631 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -57.95 -56.98 29.16 Favored Pre-proline 0 N--CA 1.505 2.288 0 C-N-CA 117.726 -1.589 . . . . 0.0 108.457 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.463 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.4 Cg_endo -38.79 -52.85 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 123.638 2.892 . . . . 0.0 108.187 170.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.44 -41.94 77.3 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 122.873 1.321 . . . . 0.0 112.055 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.631 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -64.39 -50.21 77.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 112.269 -2.241 . . . . 0.0 109.828 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -64.75 -34.33 78.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.6 -6.91 47.43 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 112.265 -2.243 . . . . 0.0 110.546 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 16.1 tpt180 -101.01 -48.69 4.35 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.75 -48.47 81.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.857 -1.52 . . . . 0.0 114.142 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -48.3 -50.75 28.89 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 79.1 ttt180 -54.24 -71.77 0.07 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 112.891 -1.958 . . . . 0.0 112.968 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.77 -41.18 43.63 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -148.43 81.54 7.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.574 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.35 175.96 10.68 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.463 2.775 . . . . 0.0 112.379 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.86 60.33 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 113.013 -1.903 . . . . 0.0 108.945 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.67 0 O-C-N 118.394 -2.692 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.816 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -172.26 177.67 44.8 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 105.621 -2.991 . . . . 0.0 105.621 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.73 -18.91 1.14 Allowed Glycine 0 N--CA 1.506 3.362 0 CA-C-N 117.918 0.859 . . . . 0.0 114.308 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -68.88 -18.38 64.12 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.312 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -118.55 125.21 49.35 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.6 t -156.77 4.56 0.15 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.333 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -42.35 -50.97 5.02 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -52.69 -39.66 62.16 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.932 0.872 . . . . 0.0 110.673 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.0 t -68.94 -54.12 17.14 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 123.23 1.491 . . . . 0.0 108.502 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.3 t -51.78 -37.13 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 110.811 -2.904 . . . . 0.0 112.958 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.85 -18.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.232 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -88.69 -37.5 7.39 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 117.57 -2.252 . . . . 0.0 109.586 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.546 ' CE3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -49.82 -57.82 11.21 Favored Pre-proline 0 N--CA 1.502 2.149 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.465 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -44.91 -27.42 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.154 1.903 . . . . 0.0 110.651 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.17 -32.98 17.21 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.546 HG21 ' CE3' ' A' ' 12' ' ' TRP . 10.3 m -69.95 -54.17 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.083 0.944 . . . . 0.0 110.175 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -64.81 -7.74 12.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 113.323 -1.762 . . . . 0.0 112.239 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -100.65 -49.36 4.21 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.5 mmm -57.54 -38.25 74.44 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.701 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -54.83 -61.83 2.05 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -34.88 -60.03 0.46 Allowed 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.928 1.393 . . . . 0.0 113.111 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.1 -74.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 112.692 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -116.16 72.56 4.77 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.523 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -72.16 37.07 0.34 Allowed 'Trans proline' 0 N--CA 1.503 2.057 1 C-N-CA 125.491 4.127 . . . . 0.0 113.491 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.4 -16.93 60.87 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.195 0.998 . . . . 0.0 110.618 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.727 0 O-C-N 119.092 -2.255 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.83 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 98.24 -2.13 59.33 Favored Glycine 0 N--CA 1.503 3.155 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.88 -150.85 8.18 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -44.2 -36.28 2.61 Favored 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.451 ' C ' ' H ' ' A' ' 6' ' ' LYS . 77.3 m95 -59.09 -28.97 67.0 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.45 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.0 m -80.1 20.79 0.62 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 4' ' ' TRP . 22.8 pttm -28.26 -49.87 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.725 2.01 . . . . 0.0 116.027 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.2 p -44.66 -48.42 10.57 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 124.745 2.212 . . . . 0.0 111.57 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -43.01 99.81 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 110.959 -2.837 . . . . 0.0 109.347 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 t -63.14 -28.33 44.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 110.046 -3.252 . . . . 0.0 109.468 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.2 mt -91.23 -23.55 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.874 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.5 -36.36 9.67 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 117.879 -2.105 . . . . 0.0 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.4 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -49.47 -59.37 6.76 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.073 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 12' ' ' TRP . 18.5 Cg_endo -43.34 -28.3 1.51 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.269 2.646 . . . . 0.0 111.604 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.29 -49.62 12.16 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 124.203 1.954 . . . . 0.0 107.204 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.53 -51.16 60.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.735 -2.938 . . . . 0.0 110.473 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -61.37 -37.71 84.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.94 -15.39 59.05 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 117.393 -1.723 . . . . 0.0 112.355 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.44 -54.06 2.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.0 mmm -54.59 -32.59 58.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.547 -2.115 . . . . 0.0 114.255 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -51.59 -62.13 1.82 Allowed 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -40.47 -61.57 0.9 Allowed 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.753 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.95 -62.93 1.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 25' ' ' ALA . 33.1 mt-10 -131.89 75.56 75.49 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.499 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.98 26.22 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 124.819 3.679 . . . . 0.0 113.408 -176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -95.81 -23.97 16.69 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.486 0 O-C-N 119.507 -1.995 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.768 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -91.32 -21.0 36.37 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.96 -179.89 47.69 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.954 -1.117 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -42.75 -8.38 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -61.15 -21.52 63.83 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 119.021 0.828 . . . . 0.0 110.042 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.2 m -113.41 19.52 16.87 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.016 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -39.38 -48.21 1.88 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.982 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.4 p -50.97 -46.48 61.22 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.779 1.276 . . . . 0.0 111.406 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 m -61.27 -48.14 82.79 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 124.034 1.873 . . . . 0.0 108.96 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.97 -29.92 32.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 109.653 -3.43 . . . . 0.0 112.055 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.89 -24.64 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.25 -28.48 14.87 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 118.475 -1.822 . . . . 0.0 111.604 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.614 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.4 -59.15 12.91 Favored Pre-proline 0 N--CA 1.495 1.785 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.02 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.3 Cg_endo -41.9 -43.19 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.725 2.283 . . . . 0.0 109.351 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.76 92.64 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 123.068 1.413 . . . . 0.0 110.281 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.614 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -66.24 -51.88 54.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.612 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -64.99 -32.97 74.96 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -67.72 -15.64 63.74 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.012 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HB2' ' NH2' ' A' ' 18' ' ' ARG . 35.8 ttm105 -100.06 -39.1 8.28 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.479 1.133 . . . . 0.0 109.004 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.4 mtp -69.14 -50.14 50.52 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.014 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -55.51 -51.01 68.43 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -49.71 -68.03 0.21 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.178 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.19 63.19 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -149.33 83.03 6.68 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.03 174.98 11.44 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 124.111 3.207 . . . . 0.0 111.991 174.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.04 66.14 0.8 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.6 -1.637 . . . . 0.0 108.741 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.7 0 O-C-N 118.723 -2.486 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.748 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 70.96 -69.43 0.79 Allowed Glycine 0 N--CA 1.498 2.824 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.73 153.32 10.26 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.281 -1.927 . . . . 0.0 108.281 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -42.3 -41.85 2.93 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -59.17 -38.09 78.92 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.664 1.221 . . . . 0.0 109.412 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.6 m -97.46 13.41 29.95 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.719 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -97.67 -40.47 8.58 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 p -91.51 -62.98 1.32 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 123.158 1.456 . . . . 0.0 113.257 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t -42.43 -41.98 3.09 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 113.084 -1.871 . . . . 0.0 112.921 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.26 -25.85 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 111.327 -2.67 . . . . 0.0 113.813 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 42.1 mt -93.0 -35.16 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 122.566 1.174 . . . . 0.0 110.042 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -38.74 66.72 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 118.309 -1.9 . . . . 0.0 110.233 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.533 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -54.61 -61.44 5.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 117.629 -1.628 . . . . 0.0 112.902 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.432 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 25.7 Cg_endo -47.98 -20.6 2.17 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.659 1.573 . . . . 0.0 110.337 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 -32.44 16.64 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 123.843 1.782 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -73.41 -49.25 38.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 112.063 -2.335 . . . . 0.0 108.637 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -61.92 -37.46 84.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -63.94 -17.37 63.18 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 110.963 -2.835 . . . . 0.0 110.664 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.9 ttm180 -101.2 -41.91 6.54 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.503 1.62 . . . . 0.0 109.669 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 63.4 mtp -63.66 -34.8 78.66 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.682 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -56.36 -63.59 1.14 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 12.2 tpt180 -36.68 -61.57 0.53 Allowed 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.504 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.85 -60.77 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 25' ' ' ALA . 34.6 mt-10 -137.75 72.87 48.34 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.107 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.65 15.62 0.14 Allowed 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 125.003 3.802 . . . . 0.0 113.852 -170.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -105.39 -13.85 15.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 O-C-N 118.944 -2.347 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.652 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 169.06 -170.42 42.47 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.48 -91.42 0.11 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 105.737 -2.945 . . . . 0.0 105.737 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.28 67.82 2.58 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -60.04 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.768 1.27 . . . . 0.0 109.664 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m -114.45 78.2 1.13 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 112.88 -1.963 . . . . 0.0 107.07 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -31.74 -62.21 0.21 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 124.067 0.854 . . . . 0.0 113.076 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.83 -39.55 25.9 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.84 0.829 . . . . 0.0 112.367 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.4 t -66.74 -47.19 73.05 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 123.897 1.808 . . . . 0.0 106.733 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.03 -28.32 40.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 110.841 -2.891 . . . . 0.0 111.385 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.4 mt -93.06 -21.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.8 -29.99 10.08 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 118.688 -1.72 . . . . 0.0 110.629 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.632 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -53.59 -57.12 18.63 Favored Pre-proline 0 N--CA 1.496 1.855 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.115 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.463 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.0 Cg_endo -41.03 -43.0 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 123.475 2.784 . . . . 0.0 110.097 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.22 94.5 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 123.494 1.616 . . . . 0.0 108.276 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.632 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -62.01 -48.18 89.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 111.382 -2.645 . . . . 0.0 110.283 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.412 ' N ' HG11 ' A' ' 15' ' ' VAL . 23.9 ttp85 -64.27 -34.77 78.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -75.33 -6.18 48.61 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 14.3 ttm180 -100.71 -40.02 7.56 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 123.867 1.794 . . . . 0.0 107.877 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 70.9 mtp -65.82 -46.64 77.84 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.572 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -50.13 -59.23 4.13 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -43.67 -63.31 0.87 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.486 178.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.18 -43.71 42.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -153.28 81.58 5.01 Favored Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.725 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.38 53.65 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 124.58 3.52 . . . . 0.0 115.29 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.99 -68.64 0.79 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 118.827 -2.421 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.763 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -114.34 141.96 17.28 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -167.8 168.48 40.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -74.54 50.07 0.41 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 118.116 0.958 . . . . 0.0 113.512 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -129.33 -79.96 0.56 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 m -74.98 11.73 1.03 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.781 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.93 -45.42 7.64 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.084 0.945 . . . . 0.0 110.022 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -53.69 -43.41 68.9 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.095 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p -76.63 -44.22 35.03 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.524 -1.67 . . . . 0.0 109.217 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.7 t -48.33 -34.78 5.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.312 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.6 mt -91.25 -22.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.039 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.3 -21.04 25.87 Favored Glycine 0 N--CA 1.505 3.278 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -57.15 17.95 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -40.75 -43.49 4.51 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.641 2.227 . . . . 0.0 109.281 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.74 72.42 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 123.748 1.737 . . . . 0.0 108.902 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' O ' ' SD ' ' A' ' 19' ' ' MET . 6.3 t -56.84 -60.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 110.117 -3.219 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -61.35 -29.01 69.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 116.578 -2.049 . . . . 0.0 109.777 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.93 -12.66 60.41 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 115.792 -2.363 . . . . 0.0 111.187 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.479 ' HB3' ' SD ' ' A' ' 19' ' ' MET . 44.7 ttm180 -101.56 -47.06 4.77 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 123.716 1.722 . . . . 0.0 108.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -62.26 -40.24 95.54 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.932 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -54.32 -63.61 1.1 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -36.19 -62.47 0.44 Allowed 'General case' 0 N--CA 1.512 2.652 0 O-C-N 123.765 0.666 . . . . 0.0 112.052 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.06 -39.21 41.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.11 83.36 3.82 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -74.26 58.02 4.23 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.7 2.933 . . . . 0.0 108.496 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -174.64 -29.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.581 -1.645 . . . . 0.0 107.84 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.453 0 O-C-N 118.776 -2.452 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -39.98 -40.56 1.74 Allowed Glycine 0 N--CA 1.505 3.297 0 N-CA-C 114.104 0.402 . . . . 0.0 114.104 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.34 -36.23 45.34 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.546 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -94.56 24.67 4.43 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.247 1.022 . . . . 0.0 111.522 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -132.35 -62.48 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 m -75.64 62.53 1.47 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.204 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -100.04 -92.75 0.28 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.344 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -45.47 -30.27 1.36 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.232 0.539 . . . . 0.0 111.5 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 p -60.95 -47.22 87.42 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 124.063 1.887 . . . . 0.0 108.271 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.17 -18.21 23.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 110.374 -3.103 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.403 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 35.6 mm -91.76 -36.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.594 1.187 . . . . 0.0 110.731 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.19 -26.92 42.15 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.904 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.601 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.4 -59.8 12.69 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 117.91 -1.516 . . . . 0.0 110.457 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.474 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -42.45 -42.59 8.05 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.66 2.24 . . . . 0.0 108.885 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -44.97 95.05 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 123.876 1.798 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.601 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -60.27 -55.68 22.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 111.013 -2.812 . . . . 0.0 109.447 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' N ' HG11 ' A' ' 15' ' ' VAL . 3.2 ttp180 -65.97 -30.65 71.25 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 116.659 -2.017 . . . . 0.0 107.166 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.89 -13.5 62.21 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.171 -1.811 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -100.76 -49.85 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -59.18 -38.55 80.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.659 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -51.06 -62.96 1.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -38.05 -64.61 0.39 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.392 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.91 -60.77 2.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.14 76.02 70.19 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.672 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -72.45 36.22 0.34 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 124.62 3.547 . . . . 0.0 114.259 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.16 44.95 0.6 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.7 1.238 . . . . 0.0 108.355 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.703 0 O-C-N 118.603 -2.56 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.713 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 75.68 -41.84 1.47 Allowed Glycine 0 N--CA 1.506 3.305 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 44.9 -93.46 0.01 OUTLIER Glycine 0 N--CA 1.501 2.975 0 CA-C-O 119.866 -0.408 . . . . 0.0 112.985 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.78 -40.3 92.06 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.549 0.69 . . . . 0.0 109.932 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -72.58 -31.57 65.33 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.833 -1.147 . . . . 0.0 108.046 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.4 m -78.29 47.22 0.67 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -100.58 -54.48 2.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.623 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 p -90.97 -66.68 0.91 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.685 1.231 . . . . 0.0 113.789 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -50.26 -26.8 5.12 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.647 -1.615 . . . . 0.0 114.55 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.05 -27.42 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.705 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.25 -14.86 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.578 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.434 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -91.38 -39.2 5.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.014 -2.041 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.54 ' CE3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -50.61 -57.41 13.35 Favored Pre-proline 0 N--CA 1.51 2.568 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.495 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.7 Cg_endo -41.21 -41.75 4.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.303 2.002 . . . . 0.0 108.335 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.75 -34.86 62.58 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.267 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.54 HG23 ' CE3' ' A' ' 12' ' ' TRP . 13.3 m -64.23 -48.2 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -62.81 -49.76 73.68 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -59.06 -12.45 4.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 112.029 -2.351 . . . . 0.0 110.689 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -99.64 -44.69 6.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 67.2 mmm -57.26 -26.33 60.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -58.75 -64.12 1.04 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -34.93 -60.4 0.45 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 124.319 1.012 . . . . 0.0 111.787 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.27 -64.51 0.79 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' C ' ' H ' ' A' ' 25' ' ' ALA . 46.6 mt-10 -126.36 69.38 68.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 124.534 1.147 . . . . 0.0 113.762 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.81 11.9 0.28 Allowed 'Trans proline' 0 N--CA 1.504 2.089 1 C-N-CA 125.421 4.081 . . . . 0.0 113.37 -169.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -94.83 -21.12 18.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.55 0 O-C-N 119.531 -1.98 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -69.62 104.86 1.38 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.02 -101.48 0.52 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.649 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -75.32 49.78 0.48 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.363 0.601 . . . . 0.0 110.684 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -175.74 125.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.0 m -154.85 62.73 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -34.15 -63.11 0.29 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.415 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 m -48.87 -37.75 20.49 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.512 0.672 . . . . 0.0 111.745 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m -67.54 -42.49 82.6 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.954 1.359 . . . . 0.0 108.251 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.12 -25.59 36.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 111.206 -2.724 . . . . 0.0 108.745 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.408 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 69.7 mt -90.5 -30.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.817 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.02 -29.7 27.77 Favored Glycine 0 N--CA 1.502 3.044 0 C-N-CA 118.047 -2.025 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.622 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.74 -59.09 13.41 Favored Pre-proline 0 N--CA 1.494 1.754 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 12' ' ' TRP . 15.0 Cg_endo -43.19 -36.41 5.95 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.735 2.29 . . . . 0.0 109.863 174.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.5 63.77 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 123.673 1.702 . . . . 0.0 109.143 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.622 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -60.05 -48.83 86.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.603 -2.544 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -66.32 -35.86 81.45 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.93 -12.42 61.61 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.342 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -100.73 -41.76 6.77 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.107 1.432 . . . . 0.0 109.085 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.8 mtp -63.5 -39.01 93.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.692 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -53.75 -62.35 1.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -39.62 -65.32 0.4 Allowed 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.741 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.54 47.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -155.16 84.93 3.56 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 124.284 0.99 . . . . 0.0 109.356 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.56 69.91 2.05 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 124.255 3.303 . . . . 0.0 110.568 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -176.2 -36.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 110.89 -2.868 . . . . 0.0 106.156 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.406 0 O-C-N 119.09 -2.256 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.767 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 143.85 -143.54 12.39 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 107.971 -2.051 . . . . 0.0 107.971 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -45.85 1.89 Allowed Glycine 0 N--CA 1.501 2.967 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.914 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -62.97 54.45 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -101.06 -5.1 26.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.62 -0.675 . . . . 0.0 111.733 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t -138.53 79.78 1.75 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.936 1.35 . . . . 0.0 111.703 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -36.61 9.28 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.235 -1.802 . . . . 0.0 107.079 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.8 t -105.91 -43.13 4.95 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.651 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -47.29 -47.12 25.31 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 124.007 1.86 . . . . 0.0 109.599 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.25 -26.81 3.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 110.852 -2.885 . . . . 0.0 113.158 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 mt -94.53 -18.78 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.052 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.74 -36.22 6.53 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.44 -58.56 7.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 114.178 -1.011 . . . . 0.0 109.879 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -41.88 -35.48 3.01 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.626 2.884 . . . . 0.0 110.539 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.23 58.69 Favored 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 123.886 1.803 . . . . 0.0 109.453 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.32 -51.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 110.366 -3.106 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -60.31 -37.52 80.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.8 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -71.07 -6.98 43.27 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.186 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.03 -62.77 1.2 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mmm -45.67 -35.23 3.99 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.818 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -50.75 -50.09 56.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -55.68 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.571 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.01 83.83 3.78 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.421 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.9 62.9 2.44 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 124.628 3.552 . . . . 0.0 113.813 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.68 -0.39 12.98 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 112.898 -1.955 . . . . 0.0 108.784 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.542 0 O-C-N 118.943 -2.348 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.69 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 112.19 -115.45 3.81 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.22 127.22 2.91 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -41.51 -30.03 0.19 Allowed 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.1 t-105 -59.65 -26.67 65.71 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.4 m -121.86 -2.36 9.28 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -35.73 -63.24 0.37 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 t -44.99 -43.21 8.94 Favored 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 m -74.0 -35.91 64.46 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.308 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.76 -28.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 111.936 -2.393 . . . . 0.0 107.875 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.9 -18.93 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.407 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -95.1 -34.46 6.15 Favored Glycine 0 N--CA 1.5 2.966 0 C-N-CA 118.011 -2.042 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.579 ' CE3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.36 -54.65 36.39 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.444 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -40.42 -46.24 4.4 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.268 1.979 . . . . 0.0 108.715 171.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.54 73.38 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.518 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.579 HG23 ' CE3' ' A' ' 12' ' ' TRP . 4.9 m -65.64 -51.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -55.96 -49.19 74.25 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.606 1.193 . . . . 0.0 107.829 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.54 -11.89 2.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 111.883 -2.417 . . . . 0.0 111.446 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -101.3 -51.28 3.53 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.1 mtp -53.17 -45.91 68.7 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.827 -1.533 . . . . 0.0 114.102 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -46.89 -59.15 3.27 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -41.92 -67.13 0.28 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.346 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -36.64 -51.87 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.131 0.972 . . . . 0.0 112.857 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.43 83.41 3.69 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 124.801 1.313 . . . . 0.0 112.646 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -74.28 38.45 0.49 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 124.576 3.517 . . . . 0.0 113.089 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.3 39.39 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.722 0 O-C-N 118.964 -2.335 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.754 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -131.38 141.82 13.15 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 107.281 -2.328 . . . . 0.0 107.281 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.84 -79.66 0.19 Allowed Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.83 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -40.97 -30.29 0.13 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -58.65 -33.05 69.66 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.072 0.939 . . . . 0.0 109.509 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 m -117.4 28.11 8.67 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.719 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -100.3 -40.58 7.45 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 118.417 -1.313 . . . . 0.0 110.129 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 p -90.3 -68.68 0.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.567 1.175 . . . . 0.0 113.024 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 m -42.58 -40.79 2.81 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.382 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.71 -31.03 28.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.242 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -94.97 -12.0 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.222 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.61 -36.3 5.64 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.069 -2.015 . . . . 0.0 110.075 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.529 ' CE3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.37 -56.23 22.22 Favored Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.478 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.8 Cg_endo -40.66 -39.79 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.202 1.935 . . . . 0.0 108.894 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.53 -36.34 44.96 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.243 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.529 HG21 ' CE3' ' A' ' 12' ' ' TRP . 22.1 m -61.99 -41.74 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -69.57 -50.46 44.52 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -61.49 -11.53 11.18 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.895 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 54.0 ttp180 -100.38 -38.81 8.28 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.984 1.373 . . . . 0.0 108.549 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.9 mmt -70.6 -39.93 73.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.318 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -59.68 -57.48 12.74 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 22.4 ttt-85 -41.48 -63.59 0.68 Allowed 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.645 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.72 64.82 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.6 78.36 10.93 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 124.454 1.096 . . . . 0.0 112.834 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.82 4.53 3.06 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 123.593 2.862 . . . . 0.0 113.276 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.77 -28.62 8.33 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.52 0 O-C-N 118.907 -2.371 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.858 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 165.7 -165.93 38.25 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' TRP . . . 146.12 -145.93 15.47 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 118.67 -1.728 . . . . 0.0 110.793 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.75 -8.79 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' C ' ' H ' ' A' ' 6' ' ' LYS . 93.5 m95 -87.36 -32.93 19.35 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.946 0.879 . . . . 0.0 110.217 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -62.41 13.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 4' ' ' TRP . 11.5 mmpt? -42.13 -43.95 3.48 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.3 t -50.36 -18.36 0.62 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.727 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t -112.56 -15.0 13.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.091 0.869 . . . . 0.0 109.801 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.41 -22.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 124.368 1.043 . . . . 0.0 111.745 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.23 -14.29 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.75 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -92.31 -36.43 6.25 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 118.591 -1.766 . . . . 0.0 109.719 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.53 ' CE3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.65 -55.9 25.75 Favored Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 18.3 Cg_endo -43.99 -24.47 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.379 2.719 . . . . 0.0 111.335 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.76 -38.96 12.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.53 HG21 ' CE3' ' A' ' 12' ' ' TRP . 8.8 m -64.21 -49.4 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -61.18 -44.9 96.57 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -12.04 23.7 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.394 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 30.8 ttt85 -101.19 -47.87 4.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 124.142 1.925 . . . . 0.0 107.53 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.3 mmt -63.94 -40.21 95.93 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.153 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -56.87 -59.16 5.44 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 41.0 tpt85 -37.83 -59.21 0.84 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.265 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.31 -55.1 20.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.28 72.55 81.86 Favored Pre-proline 0 N--CA 1.493 1.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.773 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 5.0 Cg_endo -77.56 46.92 2.14 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 125.105 3.87 . . . . 0.0 111.742 -173.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.11 -26.56 66.76 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.223 1.011 . . . . 0.0 111.775 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.682 0 O-C-N 118.397 -2.689 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.831 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 161.64 -165.93 35.84 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 106.712 -2.555 . . . . 0.0 106.712 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 137.86 -155.44 23.21 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.0 -53.85 3.05 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -159.35 -87.8 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -75.06 61.74 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -100.6 -61.97 1.3 Allowed 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 t -97.08 -53.51 3.48 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.927 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -50.75 -33.76 24.45 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.683 1.23 . . . . 0.0 113.267 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.93 -25.28 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 112.311 -2.222 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mt -90.51 -13.31 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.564 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -97.42 -37.36 4.57 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.707 -1.711 . . . . 0.0 109.477 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.574 ' CE3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -48.0 -54.6 23.05 Favored Pre-proline 0 N--CA 1.513 2.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.459 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.7 Cg_endo -39.71 -49.21 3.44 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.784 2.323 . . . . 0.0 108.823 172.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.83 -37.49 84.6 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.855 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.574 HG23 ' CE3' ' A' ' 12' ' ' TRP . 4.0 m -63.4 -52.46 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -56.51 -49.46 74.68 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.578 1.18 . . . . 0.0 108.493 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -15.27 10.33 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ttm105 -101.62 -41.41 6.59 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.094 0.949 . . . . 0.0 109.011 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 78.1 mtp -56.18 -41.08 74.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.268 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.6 ttt-85 -48.68 -69.31 0.12 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -32.46 -59.29 0.32 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 114.713 -1.131 . . . . 0.0 113.11 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.36 19.29 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.816 0.847 . . . . 0.0 112.918 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -141.32 83.05 13.91 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.311 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.31 63.2 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 124.36 3.373 . . . . 0.0 115.126 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.16 -31.54 10.54 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.338 -1.756 . . . . 0.0 109.554 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.52 0 O-C-N 118.65 -2.531 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.821 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 151.41 -86.58 0.14 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.29 -62.42 3.74 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 5' ' ' SER . 64.6 mttm -39.1 -68.8 0.15 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.887 0.851 . . . . 0.0 112.341 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 20.0 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.185 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 3' ' ' LYS . 70.6 m -147.25 11.69 1.03 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.42 -53.9 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.25 0.969 . . . . 0.0 111.907 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 p -52.76 -42.31 64.86 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.317 1.056 . . . . 0.0 111.711 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 m -68.47 -40.35 81.04 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.749 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.52 -33.15 50.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.962 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.427 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 76.3 mt -90.89 -31.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.627 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.63 -34.52 43.83 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.258 -1.925 . . . . 0.0 110.985 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.519 ' CE3' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.32 -59.59 10.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 21.6 Cg_endo -47.21 -22.84 2.58 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.022 1.815 . . . . 0.0 109.891 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.48 -37.1 14.14 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.874 -1.13 . . . . 0.0 108.783 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG13 ' CE3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -66.12 -47.79 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.444 -179.483 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.404 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 45.3 ttt180 -64.0 -38.94 92.92 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.48 -2.62 17.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 111.707 -2.497 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -101.0 -64.5 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 101.709 -3.441 . . . . 0.0 101.709 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 34.3 mtm -47.28 -37.66 11.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.387 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.3 -56.67 11.79 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -42.94 -64.58 0.6 Allowed 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.153 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.62 -42.84 25.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.768 1.227 . . . . 0.0 113.096 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -152.65 84.49 4.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.892 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -179.42 4.68 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 124.083 3.188 . . . . 0.0 111.471 174.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.13 63.22 0.69 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.581 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.6 0 O-C-N 118.66 -2.525 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.806 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 76.21 -66.48 2.56 Favored Glycine 0 N--CA 1.499 2.874 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.46 133.45 2.58 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -40.48 -50.45 2.91 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -81.69 6.81 14.13 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -113.8 61.14 0.66 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -100.14 -78.09 0.52 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.05 -43.36 40.75 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.889 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -72.84 -16.81 61.59 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 117.655 -1.618 . . . . 0.0 111.105 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.23 -32.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 125.62 1.825 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.422 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 71.3 mt -89.24 -22.51 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.433 ' O ' HG11 ' A' ' 15' ' ' VAL . . . -87.34 -37.87 8.01 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 116.96 -2.543 . . . . 0.0 109.643 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.569 ' CE3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -47.02 -57.38 9.32 Favored Pre-proline 0 N--CA 1.513 2.682 0 O-C-N 123.816 0.362 . . . . 0.0 110.64 -179.453 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.2 Cg_endo -40.68 -44.48 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.67 2.246 . . . . 0.0 108.435 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.34 74.07 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.805 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.569 HG23 ' CE3' ' A' ' 12' ' ' TRP . 5.9 m -63.54 -53.78 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.6 ttp85 -59.02 -45.05 91.68 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.89 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.67 -11.16 15.45 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.039 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 -100.86 -50.96 3.68 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.6 mmt -58.78 -39.53 81.34 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -53.42 -56.23 18.54 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 103.522 -2.769 . . . . 0.0 103.522 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -44.69 -65.99 0.45 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.982 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.69 -68.05 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.24 82.67 61.96 Favored Pre-proline 0 N--CA 1.493 1.697 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.194 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.96 -168.05 0.51 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 124.56 3.507 . . . . 0.0 113.14 173.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.4 55.32 0.11 Allowed 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.269 1.033 . . . . 0.0 113.429 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.742 0 O-C-N 117.856 -3.028 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.799 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -152.98 -129.22 1.38 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.77 163.88 30.56 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -19.24 -81.89 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.468 ' C ' ' H ' ' A' ' 6' ' ' LYS . 9.5 t-105 -167.22 -80.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.62 31.55 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.325 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 4' ' ' TRP . 41.5 tttm -41.14 -57.88 1.94 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 123.167 0.587 . . . . 0.0 111.823 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -55.64 -36.16 66.72 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.833 0.825 . . . . 0.0 110.507 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -65.98 -44.63 84.36 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 123.089 1.423 . . . . 0.0 108.355 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.36 -28.37 39.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.992 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.1 mt -90.09 -23.85 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.862 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.77 -27.46 12.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.588 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.605 ' CE3' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.96 -58.35 18.27 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.8 Cg_endo -38.91 -48.22 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.773 2.315 . . . . 0.0 108.632 172.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.08 93.32 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.394 1.092 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.605 HG11 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -66.32 -46.41 87.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.527 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -67.24 -36.62 82.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -7.45 50.47 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.057 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -101.5 -45.83 5.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 124.041 1.877 . . . . 0.0 106.731 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 42.2 mtm -66.27 -40.59 90.23 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 112.215 -2.266 . . . . 0.0 110.955 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -57.33 -51.66 68.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -48.4 -68.49 0.18 Allowed 'General case' 0 N--CA 1.513 2.723 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.18 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.49 -45.09 12.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.06 85.3 4.3 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.638 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.47 66.9 1.12 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 124.54 3.493 . . . . 0.0 111.906 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -172.33 -39.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 111.549 -2.569 . . . . 0.0 106.015 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.446 0 O-C-N 119.265 -2.147 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.831 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 169.63 -164.07 37.57 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.14 147.24 15.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 104.592 -3.403 . . . . 0.0 104.592 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.406 ' HZ1' ' CB ' ' A' ' 3' ' ' LYS . 9.7 mtmp? -70.48 62.45 0.25 Allowed 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -85.81 -38.95 17.61 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.392 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 m -72.51 35.69 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG3' ' H ' ' A' ' 7' ' ' SER . 36.8 pttt -38.39 -57.89 1.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.464 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 1.1 m -51.23 -34.85 34.04 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.495 0.664 . . . . 0.0 111.585 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t -70.77 -47.44 59.57 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 123.95 1.833 . . . . 0.0 107.304 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.76 -32.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 110.877 -2.874 . . . . 0.0 113.426 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.0 mt -90.85 -25.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.657 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.23 -30.33 19.98 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.461 -1.828 . . . . 0.0 110.893 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.585 ' CE3' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.95 -59.19 12.34 Favored Pre-proline 0 N--CA 1.496 1.838 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.583 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.479 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 19.1 Cg_endo -43.95 -42.57 12.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.938 2.426 . . . . 0.0 108.959 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.31 -44.18 97.09 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 124.0 1.857 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.585 HG13 ' CE3' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -59.05 -55.84 20.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 110.583 -3.008 . . . . 0.0 109.687 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.484 ' N ' HG13 ' A' ' 15' ' ' VAL . 52.7 ttt180 -63.6 -34.07 77.01 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.142 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.37 -8.69 56.31 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.654 -2.066 . . . . 0.0 111.081 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -101.2 -52.48 3.25 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -57.61 -44.15 85.25 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.818 -1.537 . . . . 0.0 113.704 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -49.1 -48.05 44.7 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -58.1 -75.54 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.372 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.59 -46.33 1.77 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.556 0.693 . . . . 0.0 112.79 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.28 91.04 4.55 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.941 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.22 66.3 3.49 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 123.102 2.535 . . . . 0.0 109.95 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 179.81 -32.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 110.95 -2.841 . . . . 0.0 106.32 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.423 0 O-C-N 119.298 -2.126 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 122.642 1.21 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.5 t -58.9 -29.61 41.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.537 -2.574 . . . . 0.0 109.171 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 82.8 mt -89.03 -20.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.993 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -92.59 -34.5 6.94 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 117.969 -2.062 . . . . 0.0 110.179 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.563 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.19 -56.43 20.19 Favored Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.5 Cg_endo -40.49 -40.49 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.008 2.472 . . . . 0.0 108.819 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.45 61.53 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 118.586 -1.246 . . . . 0.0 109.129 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.563 HG22 ' CE3' ' A' ' 12' ' ' TRP . 5.2 m -64.72 -52.18 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.403 ' HB2' ' CE3' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -59.58 -47.78 84.24 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.44 -5.0 6.53 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 117.572 -1.651 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 18' ' ' ARG . 69.3 ttt-85 -100.63 -56.1 2.42 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mmm -54.66 -39.49 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.335 -1.302 . . . . 0.0 114.206 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -48.24 -62.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -40.54 -64.25 0.54 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.485 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.75 -46.16 20.24 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -146.44 74.82 12.62 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.499 1.798 0 C-N-CA 125.036 3.824 . . . . 0.0 113.361 -169.345 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 N--CA 1.502 2.129 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 12.5 p -64.34 -26.93 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 122.312 1.054 . . . . 0.0 108.239 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -82.2 -13.5 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.342 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.06 -28.37 10.0 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.522 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.681 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -57.95 -56.98 29.16 Favored Pre-proline 0 N--CA 1.505 2.288 0 C-N-CA 117.726 -1.589 . . . . 0.0 108.457 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.543 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.4 Cg_endo -38.79 -52.85 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 123.638 2.892 . . . . 0.0 108.187 170.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.44 -41.94 77.3 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 122.873 1.321 . . . . 0.0 112.055 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.681 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -64.39 -50.21 77.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 112.269 -2.241 . . . . 0.0 109.828 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -64.75 -34.33 78.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.6 -6.91 47.43 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 112.265 -2.243 . . . . 0.0 110.546 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 16.1 tpt180 -101.01 -48.69 4.35 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.75 -48.47 81.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.857 -1.52 . . . . 0.0 114.142 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -48.3 -50.75 28.89 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 79.1 ttt180 -54.24 -71.77 0.07 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 112.891 -1.958 . . . . 0.0 112.968 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.77 -41.18 43.63 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -148.43 81.54 7.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.574 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 C--N 1.31 -1.487 0 C-N-CA 123.463 2.775 . . . . 0.0 112.379 174.86 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 123.23 1.491 . . . . 0.0 108.502 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.3 t -51.78 -37.13 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 110.811 -2.904 . . . . 0.0 112.958 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.85 -18.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.232 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -88.69 -37.5 7.39 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 117.57 -2.252 . . . . 0.0 109.586 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -49.82 -57.82 11.21 Favored Pre-proline 0 N--CA 1.502 2.149 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.465 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -44.91 -27.42 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.154 1.903 . . . . 0.0 110.651 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.17 -32.98 17.21 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.535 HG22 ' CE3' ' A' ' 12' ' ' TRP . 10.3 m -69.95 -54.17 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.083 0.944 . . . . 0.0 110.175 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -64.81 -7.74 12.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 113.323 -1.762 . . . . 0.0 112.239 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 44.7 ttm105 -100.65 -49.36 4.21 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.5 mmm -57.54 -38.25 74.44 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.701 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -54.83 -61.83 2.05 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 73.2 ttt180 -34.88 -60.03 0.46 Allowed 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.928 1.393 . . . . 0.0 113.111 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.1 -74.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 112.692 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -116.16 72.56 4.77 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.523 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 N--CA 1.503 2.057 1 C-N-CA 125.491 4.127 . . . . 0.0 113.491 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 124.154 1.931 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 t -63.14 -28.33 44.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 110.046 -3.252 . . . . 0.0 109.468 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 77.2 mt -91.23 -23.55 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.874 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.5 -36.36 9.67 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 117.879 -2.105 . . . . 0.0 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.459 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -49.47 -59.37 6.76 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.073 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.459 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 18.5 Cg_endo -43.34 -28.3 1.51 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.269 2.646 . . . . 0.0 111.604 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.29 -49.62 12.16 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 124.203 1.954 . . . . 0.0 107.204 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.53 -51.16 60.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.735 -2.938 . . . . 0.0 110.473 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -61.37 -37.71 84.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.94 -15.39 59.05 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 117.393 -1.723 . . . . 0.0 112.355 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.44 -54.06 2.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.0 mmm -54.59 -32.59 58.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.547 -2.115 . . . . 0.0 114.255 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -51.59 -62.13 1.82 Allowed 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 75.9 ttt180 -40.47 -61.57 0.9 Allowed 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.753 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.95 -62.93 1.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -131.89 75.56 75.49 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.499 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 36.8 Cg_endo . . . . . 0 N--CA 1.499 1.818 0 C-N-CA 124.819 3.679 . . . . 0.0 113.408 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 124.034 1.873 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.97 -29.92 32.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 109.653 -3.43 . . . . 0.0 112.055 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.89 -24.64 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . -91.25 -28.48 14.87 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 118.475 -1.822 . . . . 0.0 111.604 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.656 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.4 -59.15 12.91 Favored Pre-proline 0 N--CA 1.495 1.785 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.02 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.3 Cg_endo -41.9 -43.19 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.725 2.283 . . . . 0.0 109.351 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . -65.39 -39.76 92.64 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 123.068 1.413 . . . . 0.0 110.281 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.656 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -66.24 -51.88 54.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.612 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -64.99 -32.97 74.96 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -67.72 -15.64 63.74 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.012 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' HB2' ' NH2' ' A' ' 18' ' ' ARG . 35.8 ttm105 -100.06 -39.1 8.28 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.479 1.133 . . . . 0.0 109.004 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.4 mtp -69.14 -50.14 50.52 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.014 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -55.51 -51.01 68.43 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -49.71 -68.03 0.21 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.178 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.19 63.19 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -149.33 83.03 6.68 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 C--N 1.312 -1.352 0 C-N-CA 124.111 3.207 . . . . 0.0 111.991 174.023 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.505 2.277 0 CA-C-O 123.973 1.844 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.26 -25.85 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 111.327 -2.67 . . . . 0.0 113.813 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 42.1 mt -93.0 -35.16 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 122.566 1.174 . . . . 0.0 110.042 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -38.74 66.72 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 118.309 -1.9 . . . . 0.0 110.233 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.532 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -54.61 -61.44 5.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 117.629 -1.628 . . . . 0.0 112.902 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 25.7 Cg_endo -47.98 -20.6 2.17 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.659 1.573 . . . . 0.0 110.337 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 -32.44 16.64 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 123.843 1.782 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -73.41 -49.25 38.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 112.063 -2.335 . . . . 0.0 108.637 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -61.92 -37.46 84.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 14.1 tm-20 -63.94 -17.37 63.18 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 110.963 -2.835 . . . . 0.0 110.664 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.9 ttm180 -101.2 -41.91 6.54 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.503 1.62 . . . . 0.0 109.669 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 63.4 mtp -63.66 -34.8 78.66 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.682 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -56.36 -63.59 1.14 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 12.2 tpt180 -36.68 -61.57 0.53 Allowed 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.504 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.85 -60.77 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -137.75 72.87 48.34 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.107 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.502 1.989 0 C-N-CA 125.003 3.802 . . . . 0.0 113.852 -170.331 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 123.897 1.808 . . . . 0.0 106.733 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.03 -28.32 40.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 110.841 -2.891 . . . . 0.0 111.385 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 74.4 mt -93.06 -21.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.8 -29.99 10.08 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 118.688 -1.72 . . . . 0.0 110.629 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.688 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -53.59 -57.12 18.63 Favored Pre-proline 0 N--CA 1.496 1.855 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.115 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.0 Cg_endo -41.03 -43.0 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 123.475 2.784 . . . . 0.0 110.097 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.22 94.5 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 123.494 1.616 . . . . 0.0 108.276 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.688 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -62.01 -48.18 89.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 111.382 -2.645 . . . . 0.0 110.283 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 ttp85 -64.27 -34.77 78.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -75.33 -6.18 48.61 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 14.3 ttm180 -100.71 -40.02 7.56 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 123.867 1.794 . . . . 0.0 107.877 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 70.9 mtp -65.82 -46.64 77.84 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.572 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -50.13 -59.23 4.13 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -43.67 -63.31 0.87 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.486 178.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.18 -43.71 42.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -153.28 81.58 5.01 Favored Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.725 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo . . . . . 0 N--CA 1.493 1.496 0 C-N-CA 124.58 3.52 . . . . 0.0 115.29 -174.419 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.602 0.715 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.7 t -48.33 -34.78 5.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.312 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 72.6 mt -91.25 -22.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.039 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.3 -21.04 25.87 Favored Glycine 0 N--CA 1.505 3.278 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.462 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.55 -57.15 17.95 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 10.8 Cg_endo -40.75 -43.49 4.51 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.641 2.227 . . . . 0.0 109.281 172.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.74 72.42 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 123.748 1.737 . . . . 0.0 108.902 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 12' ' ' TRP . 6.3 t -56.84 -60.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 110.117 -3.219 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -61.35 -29.01 69.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 116.578 -2.049 . . . . 0.0 109.777 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.93 -12.66 60.41 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 115.792 -2.363 . . . . 0.0 111.187 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HB3' ' SD ' ' A' ' 19' ' ' MET . 44.7 ttm180 -101.56 -47.06 4.77 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 123.716 1.722 . . . . 0.0 108.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -62.26 -40.24 95.54 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.932 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -54.32 -63.61 1.1 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -36.19 -62.47 0.44 Allowed 'General case' 0 N--CA 1.512 2.652 0 O-C-N 123.765 0.666 . . . . 0.0 112.052 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.06 -39.21 41.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.11 83.36 3.82 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo . . . . . 0 N--CA 1.495 1.602 0 C-N-CA 123.7 2.933 . . . . 0.0 108.496 172.749 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 124.063 1.887 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.17 -18.21 23.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 110.374 -3.103 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 35.6 mm -91.76 -36.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.594 1.187 . . . . 0.0 110.731 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.19 -26.92 42.15 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.904 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.63 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.4 -59.8 12.69 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 117.91 -1.516 . . . . 0.0 110.457 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -42.45 -42.59 8.05 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.66 2.24 . . . . 0.0 108.885 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -44.97 95.05 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 123.876 1.798 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.63 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -60.27 -55.68 22.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 111.013 -2.812 . . . . 0.0 109.447 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.419 ' N ' HG12 ' A' ' 15' ' ' VAL . 3.2 ttp180 -65.97 -30.65 71.25 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 116.659 -2.017 . . . . 0.0 107.166 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.89 -13.5 62.21 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.171 -1.811 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -100.76 -49.85 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -59.18 -38.55 80.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.659 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -51.06 -62.96 1.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -38.05 -64.61 0.39 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.392 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.91 -60.77 2.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.14 76.02 70.19 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.672 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo . . . . . 0 N--CA 1.496 1.641 0 C-N-CA 124.62 3.547 . . . . 0.0 114.259 -175.588 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.05 -27.42 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.705 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.25 -14.86 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.578 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -91.38 -39.2 5.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.014 -2.041 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.565 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -50.61 -57.41 13.35 Favored Pre-proline 0 N--CA 1.51 2.568 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.565 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.7 Cg_endo -41.21 -41.75 4.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.303 2.002 . . . . 0.0 108.335 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.75 -34.86 62.58 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.267 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 12' ' ' TRP . 13.3 m -64.23 -48.2 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -62.81 -49.76 73.68 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -59.06 -12.45 4.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 112.029 -2.351 . . . . 0.0 110.689 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -99.64 -44.69 6.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 67.2 mmm -57.26 -26.33 60.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -58.75 -64.12 1.04 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -34.93 -60.4 0.45 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 124.319 1.012 . . . . 0.0 111.787 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.27 -64.51 0.79 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.36 69.38 68.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 124.534 1.147 . . . . 0.0 113.762 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.504 2.089 1 C-N-CA 125.421 4.081 . . . . 0.0 113.37 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 122.954 1.359 . . . . 0.0 108.251 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.12 -25.59 36.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 111.206 -2.724 . . . . 0.0 108.745 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 69.7 mt -90.5 -30.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.817 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.02 -29.7 27.77 Favored Glycine 0 N--CA 1.502 3.044 0 C-N-CA 118.047 -2.025 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.642 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.74 -59.09 13.41 Favored Pre-proline 0 N--CA 1.494 1.754 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 15.0 Cg_endo -43.19 -36.41 5.95 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.735 2.29 . . . . 0.0 109.863 174.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.5 63.77 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 123.673 1.702 . . . . 0.0 109.143 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.642 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -60.05 -48.83 86.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.603 -2.544 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -66.32 -35.86 81.45 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.93 -12.42 61.61 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.342 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -100.73 -41.76 6.77 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.107 1.432 . . . . 0.0 109.085 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.8 mtp -63.5 -39.01 93.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.692 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -53.75 -62.35 1.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 1.2 tmm_? -39.62 -65.32 0.4 Allowed 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.741 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.54 47.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -155.16 84.93 3.56 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 124.284 0.99 . . . . 0.0 109.356 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.493 1.467 0 C-N-CA 124.255 3.303 . . . . 0.0 110.568 -178.73 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.509 2.495 0 CA-C-O 124.007 1.86 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.25 -26.81 3.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 110.852 -2.885 . . . . 0.0 113.158 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.406 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 15.4 mt -94.53 -18.78 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.052 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.74 -36.22 6.53 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.407 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -47.44 -58.56 7.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 114.178 -1.011 . . . . 0.0 109.879 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.407 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 14.2 Cg_endo -41.88 -35.48 3.01 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.626 2.884 . . . . 0.0 110.539 175.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.23 58.69 Favored 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 123.886 1.803 . . . . 0.0 109.453 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.32 -51.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 110.366 -3.106 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -60.31 -37.52 80.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.8 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -71.07 -6.98 43.27 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.186 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.03 -62.77 1.2 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mmm -45.67 -35.23 3.99 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.818 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -50.75 -50.09 56.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.407 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 59.0 ttp180 -55.68 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.571 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.01 83.83 3.78 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.421 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 69.1 Cg_endo . . . . . 0 N--CA 1.497 1.699 0 C-N-CA 124.628 3.552 . . . . 0.0 113.813 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 122.573 1.177 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.76 -28.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 111.936 -2.393 . . . . 0.0 107.875 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.9 -18.93 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.407 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.452 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -95.1 -34.46 6.15 Favored Glycine 0 N--CA 1.5 2.966 0 C-N-CA 118.011 -2.042 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.578 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.36 -54.65 36.39 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.508 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -40.42 -46.24 4.4 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.268 1.979 . . . . 0.0 108.715 171.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.54 73.38 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.518 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.578 HG22 ' CE3' ' A' ' 12' ' ' TRP . 4.9 m -65.64 -51.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -55.96 -49.19 74.25 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.606 1.193 . . . . 0.0 107.829 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.54 -11.89 2.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 111.883 -2.417 . . . . 0.0 111.446 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 27.4 ttm-85 -101.3 -51.28 3.53 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.1 mtp -53.17 -45.91 68.7 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.827 -1.533 . . . . 0.0 114.102 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -46.89 -59.15 3.27 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 12.7 tpt180 -41.92 -67.13 0.28 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.346 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -36.64 -51.87 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.131 0.972 . . . . 0.0 112.857 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.43 83.41 3.69 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 124.801 1.313 . . . . 0.0 112.646 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo . . . . . 0 N--CA 1.497 1.734 0 C-N-CA 124.576 3.517 . . . . 0.0 113.089 -174.149 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.71 -31.03 28.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.242 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -94.97 -12.0 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.222 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.61 -36.3 5.64 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.069 -2.015 . . . . 0.0 110.075 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.546 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.37 -56.23 22.22 Favored Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.8 Cg_endo -40.66 -39.79 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.202 1.935 . . . . 0.0 108.894 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.53 -36.34 44.96 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.243 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 12' ' ' TRP . 22.1 m -61.99 -41.74 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -69.57 -50.46 44.52 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -61.49 -11.53 11.18 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.895 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 54.0 ttp180 -100.38 -38.81 8.28 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.984 1.373 . . . . 0.0 108.549 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.9 mmt -70.6 -39.93 73.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.318 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -59.68 -57.48 12.74 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 22.4 ttt-85 -41.48 -63.59 0.68 Allowed 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.645 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.72 64.82 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.6 78.36 10.93 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 124.454 1.096 . . . . 0.0 112.834 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 C--N 1.311 -1.436 0 C-N-CA 123.593 2.862 . . . . 0.0 113.276 -176.959 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 22.3 t -88.41 -22.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 124.368 1.043 . . . . 0.0 111.745 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.23 -14.29 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.75 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -92.31 -36.43 6.25 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 118.591 -1.766 . . . . 0.0 109.719 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -51.65 -55.9 25.75 Favored Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.515 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 18.3 Cg_endo -43.99 -24.47 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.379 2.719 . . . . 0.0 111.335 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . -90.76 -38.96 12.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.507 HG22 ' CE3' ' A' ' 12' ' ' TRP . 8.8 m -64.21 -49.4 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -61.18 -44.9 96.57 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -12.04 23.7 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.394 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 30.8 ttt85 -101.19 -47.87 4.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 124.142 1.925 . . . . 0.0 107.53 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.3 mmt -63.94 -40.21 95.93 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.153 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -56.87 -59.16 5.44 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 41.0 tpt85 -37.83 -59.21 0.84 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.265 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.31 -55.1 20.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.28 72.55 81.86 Favored Pre-proline 0 N--CA 1.493 1.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.773 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 5.0 Cg_endo . . . . . 0 N--CA 1.498 1.74 0 C-N-CA 125.105 3.87 . . . . 0.0 111.742 -173.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 122.683 1.23 . . . . 0.0 113.267 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.93 -25.28 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 112.311 -2.222 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mt -90.51 -13.31 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.564 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -97.42 -37.36 4.57 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.707 -1.711 . . . . 0.0 109.477 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.562 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -48.0 -54.6 23.05 Favored Pre-proline 0 N--CA 1.513 2.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.521 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.7 Cg_endo -39.71 -49.21 3.44 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.784 2.323 . . . . 0.0 108.823 172.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.83 -37.49 84.6 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.855 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' CE3' ' A' ' 12' ' ' TRP . 4.0 m -63.4 -52.46 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 12' ' ' TRP . 50.6 ttp180 -56.51 -49.46 74.68 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.578 1.18 . . . . 0.0 108.493 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -15.27 10.33 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 16.0 ttm105 -101.62 -41.41 6.59 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.094 0.949 . . . . 0.0 109.011 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 78.1 mtp -56.18 -41.08 74.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.268 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.6 ttt-85 -48.68 -69.31 0.12 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 16.4 ttp180 -32.46 -59.29 0.32 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 114.713 -1.131 . . . . 0.0 113.11 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.36 19.29 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.816 0.847 . . . . 0.0 112.918 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -141.32 83.05 13.91 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.311 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 N--CA 1.497 1.696 0 C-N-CA 124.36 3.373 . . . . 0.0 115.126 -175.676 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 122.845 1.307 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.52 -33.15 50.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.962 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.463 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 76.3 mt -90.89 -31.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.627 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.63 -34.52 43.83 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.258 -1.925 . . . . 0.0 110.985 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.32 -59.59 10.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.463 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 21.6 Cg_endo -47.21 -22.84 2.58 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.022 1.815 . . . . 0.0 109.891 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.48 -37.1 14.14 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.874 -1.13 . . . . 0.0 108.783 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.512 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -66.12 -47.79 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.444 -179.483 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.404 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 45.3 ttt180 -64.0 -38.94 92.92 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.48 -2.62 17.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 111.707 -2.497 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -101.0 -64.5 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 101.709 -3.441 . . . . 0.0 101.709 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 34.3 mtm -47.28 -37.66 11.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.387 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.3 -56.67 11.79 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -42.94 -64.58 0.6 Allowed 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.153 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.62 -42.84 25.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.768 1.227 . . . . 0.0 113.096 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -152.65 84.49 4.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.892 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.312 -1.359 0 C-N-CA 124.083 3.188 . . . . 0.0 111.471 174.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 120.241 0.067 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.23 -32.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 125.62 1.825 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 71.3 mt -89.24 -22.51 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -87.34 -37.87 8.01 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 116.96 -2.543 . . . . 0.0 109.643 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.544 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -47.02 -57.38 9.32 Favored Pre-proline 0 N--CA 1.513 2.682 0 O-C-N 123.816 0.362 . . . . 0.0 110.64 -179.453 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.2 Cg_endo -40.68 -44.48 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.67 2.246 . . . . 0.0 108.435 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.34 74.07 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.805 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.544 HG22 ' CE3' ' A' ' 12' ' ' TRP . 5.9 m -63.54 -53.78 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.6 ttp85 -59.02 -45.05 91.68 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.89 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.67 -11.16 15.45 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.039 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 38.0 ttt85 -100.86 -50.96 3.68 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.6 mmt -58.78 -39.53 81.34 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -53.42 -56.23 18.54 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 103.522 -2.769 . . . . 0.0 103.522 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 71.9 ttt180 -44.69 -65.99 0.45 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.982 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.69 -68.05 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.24 82.67 61.96 Favored Pre-proline 0 N--CA 1.493 1.697 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.194 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 N--CA 1.495 1.587 0 C-N-CA 124.56 3.507 . . . . 0.0 113.14 173.919 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 123.089 1.423 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.36 -28.37 39.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.992 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.428 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 74.1 mt -90.09 -23.85 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.862 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.77 -27.46 12.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.588 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.631 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.96 -58.35 18.27 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.514 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.8 Cg_endo -38.91 -48.22 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.773 2.315 . . . . 0.0 108.632 172.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.08 93.32 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.394 1.092 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.631 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -66.32 -46.41 87.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.527 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -67.24 -36.62 82.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -72.67 -7.45 50.47 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.057 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -101.5 -45.83 5.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 124.041 1.877 . . . . 0.0 106.731 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 42.2 mtm -66.27 -40.59 90.23 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 112.215 -2.266 . . . . 0.0 110.955 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -57.33 -51.66 68.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -48.4 -68.49 0.18 Allowed 'General case' 0 N--CA 1.513 2.723 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.18 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.49 -45.09 12.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.06 85.3 4.3 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.638 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 N--CA 1.498 1.78 0 C-N-CA 124.54 3.493 . . . . 0.0 111.906 179.601 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 123.95 1.833 . . . . 0.0 107.304 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.76 -32.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 110.877 -2.874 . . . . 0.0 113.426 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.436 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 72.0 mt -90.85 -25.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.657 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.23 -30.33 19.98 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.461 -1.828 . . . . 0.0 110.893 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.6 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.95 -59.19 12.34 Favored Pre-proline 0 N--CA 1.496 1.838 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.583 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.561 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 19.1 Cg_endo -43.95 -42.57 12.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.938 2.426 . . . . 0.0 108.959 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.31 -44.18 97.09 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 124.0 1.857 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.6 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -59.05 -55.84 20.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 110.583 -3.008 . . . . 0.0 109.687 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.492 ' N ' HG12 ' A' ' 15' ' ' VAL . 52.7 ttt180 -63.6 -34.07 77.01 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.142 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.37 -8.69 56.31 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.654 -2.066 . . . . 0.0 111.081 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -101.2 -52.48 3.25 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -57.61 -44.15 85.25 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.818 -1.537 . . . . 0.0 113.704 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -49.1 -48.05 44.7 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -58.1 -75.54 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.372 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.59 -46.33 1.77 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.556 0.693 . . . . 0.0 112.79 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.28 91.04 4.55 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.941 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 N--CA 1.497 1.715 0 C-N-CA 123.102 2.535 . . . . 0.0 109.95 173.211 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 116.48 41.76 0.72 Allowed Glycine 0 N--CA 1.5 2.951 0 O-C-N 124.056 0.847 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.06 129.75 2.82 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.59 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -79.33 49.06 0.94 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.596 0.712 . . . . 0.0 110.104 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' C ' ' H ' ' A' ' 6' ' ' LYS . 5.7 m95 -125.12 -77.22 0.59 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -66.78 1.14 1.96 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 4' ' ' TRP . 53.4 tttp -31.6 -65.31 0.14 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.846 1.341 . . . . 0.0 111.641 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -50.44 -40.98 51.93 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 122.248 1.023 . . . . 0.0 112.737 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.7 m -67.44 -43.0 82.23 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.642 1.21 . . . . 0.0 109.313 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 82.5 t -58.9 -29.61 41.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.537 -2.574 . . . . 0.0 109.171 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 82.8 mt -89.03 -20.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.993 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -92.59 -34.5 6.94 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 117.969 -2.062 . . . . 0.0 110.179 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.563 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.19 -56.43 20.19 Favored Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.5 Cg_endo -40.49 -40.49 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.008 2.472 . . . . 0.0 108.819 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.45 61.53 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 118.586 -1.246 . . . . 0.0 109.129 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.563 HG22 ' CE3' ' A' ' 12' ' ' TRP . 5.2 m -64.72 -52.18 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.403 ' HB2' ' CE3' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -59.58 -47.78 84.24 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.44 -5.0 6.53 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 117.572 -1.651 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 18' ' ' ARG . 69.3 ttt-85 -100.63 -56.1 2.42 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mmm -54.66 -39.49 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.335 -1.302 . . . . 0.0 114.206 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -48.24 -62.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -40.54 -64.25 0.54 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.485 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.75 -46.16 20.24 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -146.44 74.82 12.62 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.56 25.42 0.36 Allowed 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 125.036 3.824 . . . . 0.0 113.361 -169.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.16 -21.78 45.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.31 1.052 . . . . 0.0 109.439 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.642 0 O-C-N 119.483 -2.011 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -163.49 -90.24 0.08 OUTLIER Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.75 153.67 24.57 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -69.05 45.31 0.05 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.493 ' C ' ' H ' ' A' ' 6' ' ' LYS . 77.1 t-105 -161.04 -68.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 104.138 -2.542 . . . . 0.0 104.138 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.0 m -72.94 31.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.479 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 4' ' ' TRP . 57.3 pttt -100.73 -36.68 9.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.405 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 14.2 p -93.69 -75.6 0.5 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.364 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m -50.06 -19.73 0.8 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 12.5 p -64.34 -26.93 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 122.312 1.054 . . . . 0.0 108.239 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -82.2 -13.5 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.342 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.06 -28.37 10.0 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.522 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.681 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -57.95 -56.98 29.16 Favored Pre-proline 0 N--CA 1.505 2.288 0 C-N-CA 117.726 -1.589 . . . . 0.0 108.457 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.543 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.4 Cg_endo -38.79 -52.85 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 123.638 2.892 . . . . 0.0 108.187 170.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.44 -41.94 77.3 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 122.873 1.321 . . . . 0.0 112.055 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.681 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -64.39 -50.21 77.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 112.269 -2.241 . . . . 0.0 109.828 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -64.75 -34.33 78.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.6 -6.91 47.43 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 112.265 -2.243 . . . . 0.0 110.546 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 16.1 tpt180 -101.01 -48.69 4.35 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.75 -48.47 81.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.857 -1.52 . . . . 0.0 114.142 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -48.3 -50.75 28.89 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 79.1 ttt180 -54.24 -71.77 0.07 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 112.891 -1.958 . . . . 0.0 112.968 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.77 -41.18 43.63 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -148.43 81.54 7.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.574 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.35 175.96 10.68 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.463 2.775 . . . . 0.0 112.379 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.86 60.33 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 113.013 -1.903 . . . . 0.0 108.945 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.67 0 O-C-N 118.394 -2.692 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.816 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -172.26 177.67 44.8 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 105.621 -2.991 . . . . 0.0 105.621 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.73 -18.91 1.14 Allowed Glycine 0 N--CA 1.506 3.362 0 CA-C-N 117.918 0.859 . . . . 0.0 114.308 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -68.88 -18.38 64.12 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.312 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -118.55 125.21 49.35 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.6 t -156.77 4.56 0.15 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.333 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -42.35 -50.97 5.02 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -52.69 -39.66 62.16 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.932 0.872 . . . . 0.0 110.673 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.0 t -68.94 -54.12 17.14 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 123.23 1.491 . . . . 0.0 108.502 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.3 t -51.78 -37.13 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 110.811 -2.904 . . . . 0.0 112.958 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.85 -18.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.232 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -88.69 -37.5 7.39 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 117.57 -2.252 . . . . 0.0 109.586 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -49.82 -57.82 11.21 Favored Pre-proline 0 N--CA 1.502 2.149 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.465 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -44.91 -27.42 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.154 1.903 . . . . 0.0 110.651 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.17 -32.98 17.21 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.535 HG22 ' CE3' ' A' ' 12' ' ' TRP . 10.3 m -69.95 -54.17 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.083 0.944 . . . . 0.0 110.175 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -64.81 -7.74 12.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 113.323 -1.762 . . . . 0.0 112.239 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 44.7 ttm105 -100.65 -49.36 4.21 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.5 mmm -57.54 -38.25 74.44 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.701 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -54.83 -61.83 2.05 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 73.2 ttt180 -34.88 -60.03 0.46 Allowed 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.928 1.393 . . . . 0.0 113.111 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.1 -74.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 112.692 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -116.16 72.56 4.77 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.523 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -72.16 37.07 0.34 Allowed 'Trans proline' 0 N--CA 1.503 2.057 1 C-N-CA 125.491 4.127 . . . . 0.0 113.491 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.4 -16.93 60.87 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.195 0.998 . . . . 0.0 110.618 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.727 0 O-C-N 119.092 -2.255 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.83 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 98.24 -2.13 59.33 Favored Glycine 0 N--CA 1.503 3.155 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.88 -150.85 8.18 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -44.2 -36.28 2.61 Favored 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.452 ' C ' ' H ' ' A' ' 6' ' ' LYS . 77.3 m95 -59.09 -28.97 67.0 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.45 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.0 m -80.1 20.79 0.62 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 4' ' ' TRP . 22.8 pttm -28.26 -49.87 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.725 2.01 . . . . 0.0 116.027 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.2 p -44.66 -48.42 10.57 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 124.745 2.212 . . . . 0.0 111.57 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -43.01 99.81 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 110.959 -2.837 . . . . 0.0 109.347 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 t -63.14 -28.33 44.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 110.046 -3.252 . . . . 0.0 109.468 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 77.2 mt -91.23 -23.55 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.874 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.5 -36.36 9.67 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 117.879 -2.105 . . . . 0.0 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.459 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -49.47 -59.37 6.76 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.073 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.459 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 18.5 Cg_endo -43.34 -28.3 1.51 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.269 2.646 . . . . 0.0 111.604 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.29 -49.62 12.16 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 124.203 1.954 . . . . 0.0 107.204 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.53 -51.16 60.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.735 -2.938 . . . . 0.0 110.473 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -61.37 -37.71 84.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.94 -15.39 59.05 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 117.393 -1.723 . . . . 0.0 112.355 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.44 -54.06 2.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.0 mmm -54.59 -32.59 58.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.547 -2.115 . . . . 0.0 114.255 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -51.59 -62.13 1.82 Allowed 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 75.9 ttt180 -40.47 -61.57 0.9 Allowed 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.753 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.95 -62.93 1.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 25' ' ' ALA . 33.1 mt-10 -131.89 75.56 75.49 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.499 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 36.8 Cg_endo -69.98 26.22 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 124.819 3.679 . . . . 0.0 113.408 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -95.81 -23.97 16.69 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.486 0 O-C-N 119.507 -1.995 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.768 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -91.32 -21.0 36.37 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.96 -179.89 47.69 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.954 -1.117 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 3.6 mppt? -42.75 -8.38 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -61.15 -21.52 63.83 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 119.021 0.828 . . . . 0.0 110.042 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.2 m -113.41 19.52 16.87 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.016 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -39.38 -48.21 1.88 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.982 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.4 p -50.97 -46.48 61.22 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.779 1.276 . . . . 0.0 111.406 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 m -61.27 -48.14 82.79 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 124.034 1.873 . . . . 0.0 108.96 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.97 -29.92 32.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 109.653 -3.43 . . . . 0.0 112.055 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.89 -24.64 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . -91.25 -28.48 14.87 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 118.475 -1.822 . . . . 0.0 111.604 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.656 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.4 -59.15 12.91 Favored Pre-proline 0 N--CA 1.495 1.785 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.02 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.3 Cg_endo -41.9 -43.19 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.725 2.283 . . . . 0.0 109.351 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . -65.39 -39.76 92.64 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 123.068 1.413 . . . . 0.0 110.281 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.656 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -66.24 -51.88 54.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.612 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -64.99 -32.97 74.96 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -67.72 -15.64 63.74 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.012 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' HB2' ' NH2' ' A' ' 18' ' ' ARG . 35.8 ttm105 -100.06 -39.1 8.28 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.479 1.133 . . . . 0.0 109.004 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.4 mtp -69.14 -50.14 50.52 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.014 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -55.51 -51.01 68.43 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -49.71 -68.03 0.21 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.178 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.19 63.19 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -149.33 83.03 6.68 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.03 174.98 11.44 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 124.111 3.207 . . . . 0.0 111.991 174.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.04 66.14 0.8 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.6 -1.637 . . . . 0.0 108.741 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.7 0 O-C-N 118.723 -2.486 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.748 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 70.96 -69.43 0.79 Allowed Glycine 0 N--CA 1.498 2.824 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.73 153.32 10.26 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.281 -1.927 . . . . 0.0 108.281 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 2.7 mppt? -42.3 -41.85 2.93 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -59.17 -38.09 78.92 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.664 1.221 . . . . 0.0 109.412 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.6 m -97.46 13.41 29.95 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.719 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -97.67 -40.47 8.58 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 p -91.51 -62.98 1.32 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 123.158 1.456 . . . . 0.0 113.257 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t -42.43 -41.98 3.09 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 113.084 -1.871 . . . . 0.0 112.921 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.26 -25.85 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 111.327 -2.67 . . . . 0.0 113.813 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 42.1 mt -93.0 -35.16 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 122.566 1.174 . . . . 0.0 110.042 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -38.74 66.72 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 118.309 -1.9 . . . . 0.0 110.233 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.532 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -54.61 -61.44 5.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 117.629 -1.628 . . . . 0.0 112.902 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 25.7 Cg_endo -47.98 -20.6 2.17 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.659 1.573 . . . . 0.0 110.337 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 -32.44 16.64 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 123.843 1.782 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -73.41 -49.25 38.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 112.063 -2.335 . . . . 0.0 108.637 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -61.92 -37.46 84.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 14.1 tm-20 -63.94 -17.37 63.18 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 110.963 -2.835 . . . . 0.0 110.664 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.9 ttm180 -101.2 -41.91 6.54 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.503 1.62 . . . . 0.0 109.669 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 63.4 mtp -63.66 -34.8 78.66 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.682 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -56.36 -63.59 1.14 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 12.2 tpt180 -36.68 -61.57 0.53 Allowed 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.504 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.85 -60.77 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 25' ' ' ALA . 34.6 mt-10 -137.75 72.87 48.34 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.107 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.65 15.62 0.14 Allowed 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 125.003 3.802 . . . . 0.0 113.852 -170.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -105.39 -13.85 15.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 O-C-N 118.944 -2.347 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.652 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 169.06 -170.42 42.47 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.48 -91.42 0.11 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 105.737 -2.945 . . . . 0.0 105.737 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.28 67.82 2.58 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -60.04 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.768 1.27 . . . . 0.0 109.664 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m -114.45 78.2 1.13 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 112.88 -1.963 . . . . 0.0 107.07 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -31.74 -62.21 0.21 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 124.067 0.854 . . . . 0.0 113.076 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.83 -39.55 25.9 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.84 0.829 . . . . 0.0 112.367 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.4 t -66.74 -47.19 73.05 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 123.897 1.808 . . . . 0.0 106.733 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.03 -28.32 40.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 110.841 -2.891 . . . . 0.0 111.385 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 74.4 mt -93.06 -21.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.8 -29.99 10.08 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 118.688 -1.72 . . . . 0.0 110.629 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.688 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -53.59 -57.12 18.63 Favored Pre-proline 0 N--CA 1.496 1.855 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.115 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.0 Cg_endo -41.03 -43.0 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 123.475 2.784 . . . . 0.0 110.097 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.22 94.5 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 123.494 1.616 . . . . 0.0 108.276 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.688 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -62.01 -48.18 89.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 111.382 -2.645 . . . . 0.0 110.283 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 ttp85 -64.27 -34.77 78.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -75.33 -6.18 48.61 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 14.3 ttm180 -100.71 -40.02 7.56 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 123.867 1.794 . . . . 0.0 107.877 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 70.9 mtp -65.82 -46.64 77.84 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.572 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -50.13 -59.23 4.13 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -43.67 -63.31 0.87 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.486 178.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.18 -43.71 42.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -153.28 81.58 5.01 Favored Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.725 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.38 53.65 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 124.58 3.52 . . . . 0.0 115.29 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.99 -68.64 0.79 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 118.827 -2.421 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.763 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -114.34 141.96 17.28 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -167.8 168.48 40.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -74.54 50.07 0.41 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 118.116 0.958 . . . . 0.0 113.512 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -129.33 -79.96 0.56 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 m -74.98 11.73 1.03 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.781 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -43.93 -45.42 7.64 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.084 0.945 . . . . 0.0 110.022 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -53.69 -43.41 68.9 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.095 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p -76.63 -44.22 35.03 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.524 -1.67 . . . . 0.0 109.217 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.7 t -48.33 -34.78 5.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.312 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 72.6 mt -91.25 -22.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.039 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.3 -21.04 25.87 Favored Glycine 0 N--CA 1.505 3.278 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.462 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.55 -57.15 17.95 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 10.8 Cg_endo -40.75 -43.49 4.51 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.641 2.227 . . . . 0.0 109.281 172.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.74 72.42 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 123.748 1.737 . . . . 0.0 108.902 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 12' ' ' TRP . 6.3 t -56.84 -60.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 110.117 -3.219 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -61.35 -29.01 69.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 116.578 -2.049 . . . . 0.0 109.777 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.93 -12.66 60.41 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 115.792 -2.363 . . . . 0.0 111.187 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HB3' ' SD ' ' A' ' 19' ' ' MET . 44.7 ttm180 -101.56 -47.06 4.77 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 123.716 1.722 . . . . 0.0 108.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -62.26 -40.24 95.54 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.932 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -54.32 -63.61 1.1 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -36.19 -62.47 0.44 Allowed 'General case' 0 N--CA 1.512 2.652 0 O-C-N 123.765 0.666 . . . . 0.0 112.052 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.06 -39.21 41.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.11 83.36 3.82 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -74.26 58.02 4.23 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.7 2.933 . . . . 0.0 108.496 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -174.64 -29.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.581 -1.645 . . . . 0.0 107.84 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.453 0 O-C-N 118.776 -2.452 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -39.98 -40.56 1.74 Allowed Glycine 0 N--CA 1.505 3.297 0 N-CA-C 114.104 0.402 . . . . 0.0 114.104 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.34 -36.23 45.34 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.546 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -94.56 24.67 4.43 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.247 1.022 . . . . 0.0 111.522 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -132.35 -62.48 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 m -75.64 62.53 1.47 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.204 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -100.04 -92.75 0.28 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.344 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -45.47 -30.27 1.36 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.232 0.539 . . . . 0.0 111.5 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 p -60.95 -47.22 87.42 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 124.063 1.887 . . . . 0.0 108.271 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.17 -18.21 23.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 110.374 -3.103 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 35.6 mm -91.76 -36.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.594 1.187 . . . . 0.0 110.731 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.19 -26.92 42.15 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.904 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.63 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.4 -59.8 12.69 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 117.91 -1.516 . . . . 0.0 110.457 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -42.45 -42.59 8.05 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.66 2.24 . . . . 0.0 108.885 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -44.97 95.05 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 123.876 1.798 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.63 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -60.27 -55.68 22.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 111.013 -2.812 . . . . 0.0 109.447 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' N ' HG12 ' A' ' 15' ' ' VAL . 3.2 ttp180 -65.97 -30.65 71.25 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 116.659 -2.017 . . . . 0.0 107.166 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.89 -13.5 62.21 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.171 -1.811 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -100.76 -49.85 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -59.18 -38.55 80.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.659 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -51.06 -62.96 1.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -38.05 -64.61 0.39 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.392 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.91 -60.77 2.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.14 76.02 70.19 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.672 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -72.45 36.22 0.34 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 124.62 3.547 . . . . 0.0 114.259 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.16 44.95 0.6 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.7 1.238 . . . . 0.0 108.355 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.703 0 O-C-N 118.603 -2.56 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.713 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 75.68 -41.84 1.47 Allowed Glycine 0 N--CA 1.506 3.305 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 44.9 -93.46 0.01 OUTLIER Glycine 0 N--CA 1.501 2.975 0 CA-C-O 119.866 -0.408 . . . . 0.0 112.985 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.78 -40.3 92.06 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.549 0.69 . . . . 0.0 109.932 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -72.58 -31.57 65.33 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.833 -1.147 . . . . 0.0 108.046 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.4 m -78.29 47.22 0.67 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -100.58 -54.48 2.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.623 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 p -90.97 -66.68 0.91 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.685 1.231 . . . . 0.0 113.789 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -50.26 -26.8 5.12 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.647 -1.615 . . . . 0.0 114.55 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.05 -27.42 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.705 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.25 -14.86 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.578 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -91.38 -39.2 5.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.014 -2.041 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.565 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -50.61 -57.41 13.35 Favored Pre-proline 0 N--CA 1.51 2.568 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.565 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.7 Cg_endo -41.21 -41.75 4.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.303 2.002 . . . . 0.0 108.335 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.75 -34.86 62.58 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.267 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 12' ' ' TRP . 13.3 m -64.23 -48.2 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -62.81 -49.76 73.68 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -59.06 -12.45 4.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 112.029 -2.351 . . . . 0.0 110.689 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -99.64 -44.69 6.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 67.2 mmm -57.26 -26.33 60.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -58.75 -64.12 1.04 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -34.93 -60.4 0.45 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 124.319 1.012 . . . . 0.0 111.787 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.27 -64.51 0.79 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 25' ' ' ALA . 46.6 mt-10 -126.36 69.38 68.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 124.534 1.147 . . . . 0.0 113.762 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.81 11.9 0.28 Allowed 'Trans proline' 0 N--CA 1.504 2.089 1 C-N-CA 125.421 4.081 . . . . 0.0 113.37 -169.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -94.83 -21.12 18.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.55 0 O-C-N 119.531 -1.98 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -69.62 104.86 1.38 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.02 -101.48 0.52 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.649 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -75.32 49.78 0.48 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.363 0.601 . . . . 0.0 110.684 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -175.74 125.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.0 m -154.85 62.73 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 24.0 tptm -34.15 -63.11 0.29 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.415 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 m -48.87 -37.75 20.49 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.512 0.672 . . . . 0.0 111.745 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m -67.54 -42.49 82.6 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.954 1.359 . . . . 0.0 108.251 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 99.9 t -61.12 -25.59 36.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 111.206 -2.724 . . . . 0.0 108.745 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 69.7 mt -90.5 -30.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.817 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.02 -29.7 27.77 Favored Glycine 0 N--CA 1.502 3.044 0 C-N-CA 118.047 -2.025 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.642 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.74 -59.09 13.41 Favored Pre-proline 0 N--CA 1.494 1.754 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 15.0 Cg_endo -43.19 -36.41 5.95 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.735 2.29 . . . . 0.0 109.863 174.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.5 63.77 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 123.673 1.702 . . . . 0.0 109.143 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.642 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -60.05 -48.83 86.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.603 -2.544 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -66.32 -35.86 81.45 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.93 -12.42 61.61 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.342 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -100.73 -41.76 6.77 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.107 1.432 . . . . 0.0 109.085 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.8 mtp -63.5 -39.01 93.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.692 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -53.75 -62.35 1.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 1.2 tmm_? -39.62 -65.32 0.4 Allowed 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.741 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.54 47.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -155.16 84.93 3.56 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 124.284 0.99 . . . . 0.0 109.356 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.56 69.91 2.05 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 124.255 3.303 . . . . 0.0 110.568 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -176.2 -36.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 110.89 -2.868 . . . . 0.0 106.156 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.406 0 O-C-N 119.09 -2.256 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.767 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 143.85 -143.54 12.39 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 107.971 -2.051 . . . . 0.0 107.971 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -45.85 1.89 Allowed Glycine 0 N--CA 1.501 2.967 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.914 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -62.97 54.45 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -101.06 -5.1 26.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.62 -0.675 . . . . 0.0 111.733 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t -138.53 79.78 1.75 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.936 1.35 . . . . 0.0 111.703 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.458 ' H ' ' HD3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -100.09 -36.61 9.28 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.235 -1.802 . . . . 0.0 107.079 179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.8 t -105.91 -43.13 4.95 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.651 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -47.29 -47.12 25.31 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 124.007 1.86 . . . . 0.0 109.599 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.25 -26.81 3.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 110.852 -2.885 . . . . 0.0 113.158 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.406 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 15.4 mt -94.53 -18.78 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.052 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.74 -36.22 6.53 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.407 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -47.44 -58.56 7.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 114.178 -1.011 . . . . 0.0 109.879 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 14.2 Cg_endo -41.88 -35.48 3.01 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.626 2.884 . . . . 0.0 110.539 175.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.23 58.69 Favored 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 123.886 1.803 . . . . 0.0 109.453 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.32 -51.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 110.366 -3.106 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -60.31 -37.52 80.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.8 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -71.07 -6.98 43.27 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.186 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.03 -62.77 1.2 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mmm -45.67 -35.23 3.99 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.818 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -50.75 -50.09 56.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 59.0 ttp180 -55.68 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.571 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.01 83.83 3.78 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.421 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 69.1 Cg_endo -70.9 62.9 2.44 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 124.628 3.552 . . . . 0.0 113.813 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.68 -0.39 12.98 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 112.898 -1.955 . . . . 0.0 108.784 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.542 0 O-C-N 118.943 -2.348 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.69 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 112.19 -115.45 3.81 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.22 127.22 2.91 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -41.51 -30.03 0.19 Allowed 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.1 t-105 -59.65 -26.67 65.71 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.4 m -121.86 -2.36 9.28 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -35.73 -63.24 0.37 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 t -44.99 -43.21 8.94 Favored 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 m -74.0 -35.91 64.46 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.308 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.76 -28.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 111.936 -2.393 . . . . 0.0 107.875 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.9 -18.93 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.407 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -95.1 -34.46 6.15 Favored Glycine 0 N--CA 1.5 2.966 0 C-N-CA 118.011 -2.042 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.578 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.36 -54.65 36.39 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.508 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -40.42 -46.24 4.4 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.268 1.979 . . . . 0.0 108.715 171.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.54 73.38 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.518 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.578 HG22 ' CE3' ' A' ' 12' ' ' TRP . 4.9 m -65.64 -51.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -55.96 -49.19 74.25 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.606 1.193 . . . . 0.0 107.829 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.54 -11.89 2.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 111.883 -2.417 . . . . 0.0 111.446 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 27.4 ttm-85 -101.3 -51.28 3.53 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.1 mtp -53.17 -45.91 68.7 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.827 -1.533 . . . . 0.0 114.102 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -46.89 -59.15 3.27 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 12.7 tpt180 -41.92 -67.13 0.28 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.346 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -36.64 -51.87 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.131 0.972 . . . . 0.0 112.857 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.43 83.41 3.69 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 124.801 1.313 . . . . 0.0 112.646 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -74.28 38.45 0.49 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 124.576 3.517 . . . . 0.0 113.089 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.3 39.39 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.722 0 O-C-N 118.964 -2.335 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.754 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -131.38 141.82 13.15 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 107.281 -2.328 . . . . 0.0 107.281 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.84 -79.66 0.19 Allowed Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.83 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -40.97 -30.29 0.13 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -58.65 -33.05 69.66 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.072 0.939 . . . . 0.0 109.509 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 m -117.4 28.11 8.67 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.719 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -100.3 -40.58 7.45 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 118.417 -1.313 . . . . 0.0 110.129 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 p -90.3 -68.68 0.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.567 1.175 . . . . 0.0 113.024 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 m -42.58 -40.79 2.81 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.382 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.71 -31.03 28.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.242 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -94.97 -12.0 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.222 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.61 -36.3 5.64 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.069 -2.015 . . . . 0.0 110.075 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.546 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.37 -56.23 22.22 Favored Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.8 Cg_endo -40.66 -39.79 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.202 1.935 . . . . 0.0 108.894 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.53 -36.34 44.96 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.243 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 12' ' ' TRP . 22.1 m -61.99 -41.74 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -69.57 -50.46 44.52 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -61.49 -11.53 11.18 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.895 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 54.0 ttp180 -100.38 -38.81 8.28 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.984 1.373 . . . . 0.0 108.549 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.9 mmt -70.6 -39.93 73.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.318 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -59.68 -57.48 12.74 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 22.4 ttt-85 -41.48 -63.59 0.68 Allowed 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.645 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.72 64.82 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.6 78.36 10.93 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 124.454 1.096 . . . . 0.0 112.834 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.82 4.53 3.06 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 123.593 2.862 . . . . 0.0 113.276 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.77 -28.62 8.33 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.52 0 O-C-N 118.907 -2.371 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.858 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 165.7 -165.93 38.25 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' TRP . . . 146.12 -145.93 15.47 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 118.67 -1.728 . . . . 0.0 110.793 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.75 -8.79 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' GLY . 93.5 m95 -87.36 -32.93 19.35 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.946 0.879 . . . . 0.0 110.217 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -62.41 13.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 11.5 mmpt? -42.13 -43.95 3.48 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.3 t -50.36 -18.36 0.62 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.727 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t -112.56 -15.0 13.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.091 0.869 . . . . 0.0 109.801 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 22.3 t -88.41 -22.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 124.368 1.043 . . . . 0.0 111.745 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.23 -14.29 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.75 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -92.31 -36.43 6.25 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 118.591 -1.766 . . . . 0.0 109.719 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -51.65 -55.9 25.75 Favored Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.515 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 18.3 Cg_endo -43.99 -24.47 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.379 2.719 . . . . 0.0 111.335 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . -90.76 -38.96 12.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG22 ' CE3' ' A' ' 12' ' ' TRP . 8.8 m -64.21 -49.4 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -61.18 -44.9 96.57 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -12.04 23.7 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.394 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 30.8 ttt85 -101.19 -47.87 4.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 124.142 1.925 . . . . 0.0 107.53 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.3 mmt -63.94 -40.21 95.93 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.153 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -56.87 -59.16 5.44 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 41.0 tpt85 -37.83 -59.21 0.84 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.265 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.31 -55.1 20.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.28 72.55 81.86 Favored Pre-proline 0 N--CA 1.493 1.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.773 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 5.0 Cg_endo -77.56 46.92 2.14 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 125.105 3.87 . . . . 0.0 111.742 -173.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.11 -26.56 66.76 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.223 1.011 . . . . 0.0 111.775 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.682 0 O-C-N 118.397 -2.689 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.831 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 161.64 -165.93 35.84 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 106.712 -2.555 . . . . 0.0 106.712 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 137.86 -155.44 23.21 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.0 -53.85 3.05 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -159.35 -87.8 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -75.06 61.74 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -100.6 -61.97 1.3 Allowed 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 t -97.08 -53.51 3.48 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.927 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -50.75 -33.76 24.45 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.683 1.23 . . . . 0.0 113.267 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.93 -25.28 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 112.311 -2.222 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mt -90.51 -13.31 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.564 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -97.42 -37.36 4.57 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.707 -1.711 . . . . 0.0 109.477 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.562 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -48.0 -54.6 23.05 Favored Pre-proline 0 N--CA 1.513 2.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.7 Cg_endo -39.71 -49.21 3.44 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.784 2.323 . . . . 0.0 108.823 172.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.83 -37.49 84.6 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.855 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' CE3' ' A' ' 12' ' ' TRP . 4.0 m -63.4 -52.46 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 12' ' ' TRP . 50.6 ttp180 -56.51 -49.46 74.68 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.578 1.18 . . . . 0.0 108.493 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -15.27 10.33 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 16.0 ttm105 -101.62 -41.41 6.59 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.094 0.949 . . . . 0.0 109.011 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 78.1 mtp -56.18 -41.08 74.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.268 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.6 ttt-85 -48.68 -69.31 0.12 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 16.4 ttp180 -32.46 -59.29 0.32 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 114.713 -1.131 . . . . 0.0 113.11 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.36 19.29 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.816 0.847 . . . . 0.0 112.918 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -141.32 83.05 13.91 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.311 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.31 63.2 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 124.36 3.373 . . . . 0.0 115.126 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.16 -31.54 10.54 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.338 -1.756 . . . . 0.0 109.554 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.52 0 O-C-N 118.65 -2.531 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.821 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 151.41 -86.58 0.14 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.29 -62.42 3.74 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 5' ' ' SER . 64.6 mttm -39.1 -68.8 0.15 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.887 0.851 . . . . 0.0 112.341 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 20.0 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.185 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 3' ' ' LYS . 70.6 m -147.25 11.69 1.03 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.42 -53.9 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.25 0.969 . . . . 0.0 111.907 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 p -52.76 -42.31 64.86 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.317 1.056 . . . . 0.0 111.711 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 m -68.47 -40.35 81.04 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.749 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.52 -33.15 50.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.962 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.463 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 76.3 mt -90.89 -31.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.627 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.63 -34.52 43.83 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.258 -1.925 . . . . 0.0 110.985 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.32 -59.59 10.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.463 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 21.6 Cg_endo -47.21 -22.84 2.58 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.022 1.815 . . . . 0.0 109.891 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.48 -37.1 14.14 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.874 -1.13 . . . . 0.0 108.783 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.512 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -66.12 -47.79 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.444 -179.483 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.404 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 45.3 ttt180 -64.0 -38.94 92.92 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.48 -2.62 17.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 111.707 -2.497 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -101.0 -64.5 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 101.709 -3.441 . . . . 0.0 101.709 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 34.3 mtm -47.28 -37.66 11.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.387 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.3 -56.67 11.79 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -42.94 -64.58 0.6 Allowed 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.153 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.62 -42.84 25.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.768 1.227 . . . . 0.0 113.096 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -152.65 84.49 4.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.892 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -179.42 4.68 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 124.083 3.188 . . . . 0.0 111.471 174.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.13 63.22 0.69 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.581 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.6 0 O-C-N 118.66 -2.525 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.806 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 76.21 -66.48 2.56 Favored Glycine 0 N--CA 1.499 2.874 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.46 133.45 2.58 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -40.48 -50.45 2.91 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -81.69 6.81 14.13 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -113.8 61.14 0.66 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -100.14 -78.09 0.52 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.05 -43.36 40.75 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.889 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -72.84 -16.81 61.59 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 117.655 -1.618 . . . . 0.0 111.105 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.23 -32.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 125.62 1.825 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 71.3 mt -89.24 -22.51 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -87.34 -37.87 8.01 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 116.96 -2.543 . . . . 0.0 109.643 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.544 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -47.02 -57.38 9.32 Favored Pre-proline 0 N--CA 1.513 2.682 0 O-C-N 123.816 0.362 . . . . 0.0 110.64 -179.453 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.2 Cg_endo -40.68 -44.48 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.67 2.246 . . . . 0.0 108.435 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.34 74.07 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.805 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.544 HG22 ' CE3' ' A' ' 12' ' ' TRP . 5.9 m -63.54 -53.78 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.6 ttp85 -59.02 -45.05 91.68 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.89 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.67 -11.16 15.45 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.039 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 38.0 ttt85 -100.86 -50.96 3.68 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.6 mmt -58.78 -39.53 81.34 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -53.42 -56.23 18.54 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 103.522 -2.769 . . . . 0.0 103.522 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 71.9 ttt180 -44.69 -65.99 0.45 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.982 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.69 -68.05 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.24 82.67 61.96 Favored Pre-proline 0 N--CA 1.493 1.697 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.194 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.96 -168.05 0.51 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 124.56 3.507 . . . . 0.0 113.14 173.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.4 55.32 0.11 Allowed 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.269 1.033 . . . . 0.0 113.429 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.742 0 O-C-N 117.856 -3.028 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.799 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -152.98 -129.22 1.38 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.77 163.88 30.56 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -19.24 -81.89 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.443 ' C ' ' H ' ' A' ' 6' ' ' LYS . 9.5 t-105 -167.22 -80.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.62 31.55 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.325 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 4' ' ' TRP . 41.5 tttm -41.14 -57.88 1.94 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 123.167 0.587 . . . . 0.0 111.823 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -55.64 -36.16 66.72 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.833 0.825 . . . . 0.0 110.507 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -65.98 -44.63 84.36 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 123.089 1.423 . . . . 0.0 108.355 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.36 -28.37 39.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.992 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.428 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 74.1 mt -90.09 -23.85 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.862 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.77 -27.46 12.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.588 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.631 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.96 -58.35 18.27 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.514 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.8 Cg_endo -38.91 -48.22 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.773 2.315 . . . . 0.0 108.632 172.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.08 93.32 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.394 1.092 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.631 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -66.32 -46.41 87.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.527 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -67.24 -36.62 82.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -72.67 -7.45 50.47 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.057 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -101.5 -45.83 5.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 124.041 1.877 . . . . 0.0 106.731 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 42.2 mtm -66.27 -40.59 90.23 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 112.215 -2.266 . . . . 0.0 110.955 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -57.33 -51.66 68.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -48.4 -68.49 0.18 Allowed 'General case' 0 N--CA 1.513 2.723 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.18 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.49 -45.09 12.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.06 85.3 4.3 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.638 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.47 66.9 1.12 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 124.54 3.493 . . . . 0.0 111.906 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -172.33 -39.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 111.549 -2.569 . . . . 0.0 106.015 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.446 0 O-C-N 119.265 -2.147 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.831 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 169.63 -164.07 37.57 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.14 147.24 15.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 104.592 -3.403 . . . . 0.0 104.592 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -70.48 62.45 0.25 Allowed 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -85.81 -38.95 17.61 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.392 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 m -72.51 35.69 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.512 ' HG3' ' H ' ' A' ' 7' ' ' SER . 36.8 pttt -38.39 -57.89 1.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.512 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 1.1 m -51.23 -34.85 34.04 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.495 0.664 . . . . 0.0 111.585 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t -70.77 -47.44 59.57 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 123.95 1.833 . . . . 0.0 107.304 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.76 -32.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 110.877 -2.874 . . . . 0.0 113.426 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 72.0 mt -90.85 -25.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.657 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.23 -30.33 19.98 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.461 -1.828 . . . . 0.0 110.893 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.6 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.95 -59.19 12.34 Favored Pre-proline 0 N--CA 1.496 1.838 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.583 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.561 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 19.1 Cg_endo -43.95 -42.57 12.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.938 2.426 . . . . 0.0 108.959 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.31 -44.18 97.09 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 124.0 1.857 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.6 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -59.05 -55.84 20.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 110.583 -3.008 . . . . 0.0 109.687 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.492 ' N ' HG12 ' A' ' 15' ' ' VAL . 52.7 ttt180 -63.6 -34.07 77.01 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.142 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.37 -8.69 56.31 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.654 -2.066 . . . . 0.0 111.081 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -101.2 -52.48 3.25 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -57.61 -44.15 85.25 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.818 -1.537 . . . . 0.0 113.704 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -49.1 -48.05 44.7 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -58.1 -75.54 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.372 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.59 -46.33 1.77 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.556 0.693 . . . . 0.0 112.79 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.28 91.04 4.55 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.941 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.22 66.3 3.49 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 123.102 2.535 . . . . 0.0 109.95 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 179.81 -32.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 110.95 -2.841 . . . . 0.0 106.32 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.423 0 O-C-N 119.298 -2.126 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 122.642 1.21 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.5 t -58.9 -29.61 41.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.537 -2.574 . . . . 0.0 109.171 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 82.8 mt -89.03 -20.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.993 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -92.59 -34.5 6.94 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 117.969 -2.062 . . . . 0.0 110.179 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.563 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.19 -56.43 20.19 Favored Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.5 Cg_endo -40.49 -40.49 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.008 2.472 . . . . 0.0 108.819 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.45 61.53 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 118.586 -1.246 . . . . 0.0 109.129 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.563 HG22 ' CE3' ' A' ' 12' ' ' TRP . 5.2 m -64.72 -52.18 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.403 ' HB2' ' CE3' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -59.58 -47.78 84.24 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.44 -5.0 6.53 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 117.572 -1.651 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 18' ' ' ARG . 69.3 ttt-85 -100.63 -56.1 2.42 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mmm -54.66 -39.49 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.335 -1.302 . . . . 0.0 114.206 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -48.24 -62.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -40.54 -64.25 0.54 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.485 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.75 -46.16 20.24 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -146.44 74.82 12.62 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.499 1.798 0 C-N-CA 125.036 3.824 . . . . 0.0 113.361 -169.345 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 N--CA 1.502 2.129 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 12.5 p -64.34 -26.93 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 122.312 1.054 . . . . 0.0 108.239 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -82.2 -13.5 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.342 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.06 -28.37 10.0 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.522 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.681 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -57.95 -56.98 29.16 Favored Pre-proline 0 N--CA 1.505 2.288 0 C-N-CA 117.726 -1.589 . . . . 0.0 108.457 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.543 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.4 Cg_endo -38.79 -52.85 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 123.638 2.892 . . . . 0.0 108.187 170.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.44 -41.94 77.3 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 122.873 1.321 . . . . 0.0 112.055 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.681 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -64.39 -50.21 77.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 112.269 -2.241 . . . . 0.0 109.828 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -64.75 -34.33 78.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.6 -6.91 47.43 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 112.265 -2.243 . . . . 0.0 110.546 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 16.1 tpt180 -101.01 -48.69 4.35 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.75 -48.47 81.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.857 -1.52 . . . . 0.0 114.142 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -48.3 -50.75 28.89 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 79.1 ttt180 -54.24 -71.77 0.07 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 112.891 -1.958 . . . . 0.0 112.968 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.77 -41.18 43.63 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -148.43 81.54 7.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.574 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 C--N 1.31 -1.487 0 C-N-CA 123.463 2.775 . . . . 0.0 112.379 174.86 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 123.23 1.491 . . . . 0.0 108.502 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.3 t -51.78 -37.13 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 110.811 -2.904 . . . . 0.0 112.958 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.85 -18.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.232 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -88.69 -37.5 7.39 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 117.57 -2.252 . . . . 0.0 109.586 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -49.82 -57.82 11.21 Favored Pre-proline 0 N--CA 1.502 2.149 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.465 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -44.91 -27.42 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.154 1.903 . . . . 0.0 110.651 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.17 -32.98 17.21 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.535 HG22 ' CE3' ' A' ' 12' ' ' TRP . 10.3 m -69.95 -54.17 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.083 0.944 . . . . 0.0 110.175 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -64.81 -7.74 12.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 113.323 -1.762 . . . . 0.0 112.239 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 44.7 ttm105 -100.65 -49.36 4.21 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.5 mmm -57.54 -38.25 74.44 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.701 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -54.83 -61.83 2.05 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 73.2 ttt180 -34.88 -60.03 0.46 Allowed 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.928 1.393 . . . . 0.0 113.111 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.1 -74.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 112.692 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -116.16 72.56 4.77 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.523 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 N--CA 1.503 2.057 1 C-N-CA 125.491 4.127 . . . . 0.0 113.491 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 124.154 1.931 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 t -63.14 -28.33 44.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 110.046 -3.252 . . . . 0.0 109.468 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 77.2 mt -91.23 -23.55 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.874 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.5 -36.36 9.67 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 117.879 -2.105 . . . . 0.0 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.459 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -49.47 -59.37 6.76 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.073 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.459 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 18.5 Cg_endo -43.34 -28.3 1.51 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.269 2.646 . . . . 0.0 111.604 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.29 -49.62 12.16 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 124.203 1.954 . . . . 0.0 107.204 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.53 -51.16 60.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.735 -2.938 . . . . 0.0 110.473 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -61.37 -37.71 84.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.94 -15.39 59.05 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 117.393 -1.723 . . . . 0.0 112.355 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.44 -54.06 2.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.0 mmm -54.59 -32.59 58.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.547 -2.115 . . . . 0.0 114.255 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -51.59 -62.13 1.82 Allowed 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 75.9 ttt180 -40.47 -61.57 0.9 Allowed 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.753 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.95 -62.93 1.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -131.89 75.56 75.49 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.499 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 36.8 Cg_endo . . . . . 0 N--CA 1.499 1.818 0 C-N-CA 124.819 3.679 . . . . 0.0 113.408 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 124.034 1.873 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.97 -29.92 32.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 109.653 -3.43 . . . . 0.0 112.055 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.89 -24.64 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . -91.25 -28.48 14.87 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 118.475 -1.822 . . . . 0.0 111.604 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.656 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.4 -59.15 12.91 Favored Pre-proline 0 N--CA 1.495 1.785 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.02 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.3 Cg_endo -41.9 -43.19 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.725 2.283 . . . . 0.0 109.351 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . -65.39 -39.76 92.64 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 123.068 1.413 . . . . 0.0 110.281 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.656 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -66.24 -51.88 54.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.612 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -64.99 -32.97 74.96 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -67.72 -15.64 63.74 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.012 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' HB2' ' NH2' ' A' ' 18' ' ' ARG . 35.8 ttm105 -100.06 -39.1 8.28 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.479 1.133 . . . . 0.0 109.004 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.4 mtp -69.14 -50.14 50.52 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.014 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -55.51 -51.01 68.43 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -49.71 -68.03 0.21 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.178 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.19 63.19 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -149.33 83.03 6.68 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 C--N 1.312 -1.352 0 C-N-CA 124.111 3.207 . . . . 0.0 111.991 174.023 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.505 2.277 0 CA-C-O 123.973 1.844 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.26 -25.85 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 111.327 -2.67 . . . . 0.0 113.813 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 42.1 mt -93.0 -35.16 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 122.566 1.174 . . . . 0.0 110.042 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -38.74 66.72 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 118.309 -1.9 . . . . 0.0 110.233 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.532 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -54.61 -61.44 5.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 117.629 -1.628 . . . . 0.0 112.902 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 25.7 Cg_endo -47.98 -20.6 2.17 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.659 1.573 . . . . 0.0 110.337 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 -32.44 16.64 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 123.843 1.782 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -73.41 -49.25 38.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 112.063 -2.335 . . . . 0.0 108.637 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -61.92 -37.46 84.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 14.1 tm-20 -63.94 -17.37 63.18 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 110.963 -2.835 . . . . 0.0 110.664 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.9 ttm180 -101.2 -41.91 6.54 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.503 1.62 . . . . 0.0 109.669 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 63.4 mtp -63.66 -34.8 78.66 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.682 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -56.36 -63.59 1.14 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 12.2 tpt180 -36.68 -61.57 0.53 Allowed 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.504 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.85 -60.77 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -137.75 72.87 48.34 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.107 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.502 1.989 0 C-N-CA 125.003 3.802 . . . . 0.0 113.852 -170.331 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 123.897 1.808 . . . . 0.0 106.733 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.03 -28.32 40.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 110.841 -2.891 . . . . 0.0 111.385 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 74.4 mt -93.06 -21.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.8 -29.99 10.08 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 118.688 -1.72 . . . . 0.0 110.629 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.688 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -53.59 -57.12 18.63 Favored Pre-proline 0 N--CA 1.496 1.855 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.115 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.0 Cg_endo -41.03 -43.0 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 123.475 2.784 . . . . 0.0 110.097 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.22 94.5 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 123.494 1.616 . . . . 0.0 108.276 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.688 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -62.01 -48.18 89.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 111.382 -2.645 . . . . 0.0 110.283 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 ttp85 -64.27 -34.77 78.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -75.33 -6.18 48.61 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 14.3 ttm180 -100.71 -40.02 7.56 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 123.867 1.794 . . . . 0.0 107.877 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 70.9 mtp -65.82 -46.64 77.84 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.572 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -50.13 -59.23 4.13 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -43.67 -63.31 0.87 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.486 178.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.18 -43.71 42.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -153.28 81.58 5.01 Favored Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.725 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo . . . . . 0 N--CA 1.493 1.496 0 C-N-CA 124.58 3.52 . . . . 0.0 115.29 -174.419 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.602 0.715 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.7 t -48.33 -34.78 5.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.312 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 72.6 mt -91.25 -22.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.039 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.3 -21.04 25.87 Favored Glycine 0 N--CA 1.505 3.278 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.462 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.55 -57.15 17.95 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 10.8 Cg_endo -40.75 -43.49 4.51 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.641 2.227 . . . . 0.0 109.281 172.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.74 72.42 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 123.748 1.737 . . . . 0.0 108.902 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 12' ' ' TRP . 6.3 t -56.84 -60.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 110.117 -3.219 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -61.35 -29.01 69.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 116.578 -2.049 . . . . 0.0 109.777 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.93 -12.66 60.41 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 115.792 -2.363 . . . . 0.0 111.187 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HB3' ' SD ' ' A' ' 19' ' ' MET . 44.7 ttm180 -101.56 -47.06 4.77 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 123.716 1.722 . . . . 0.0 108.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -62.26 -40.24 95.54 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.932 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -54.32 -63.61 1.1 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -36.19 -62.47 0.44 Allowed 'General case' 0 N--CA 1.512 2.652 0 O-C-N 123.765 0.666 . . . . 0.0 112.052 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.06 -39.21 41.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.11 83.36 3.82 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo . . . . . 0 N--CA 1.495 1.602 0 C-N-CA 123.7 2.933 . . . . 0.0 108.496 172.749 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 124.063 1.887 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.17 -18.21 23.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 110.374 -3.103 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 35.6 mm -91.76 -36.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.594 1.187 . . . . 0.0 110.731 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.19 -26.92 42.15 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.904 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.63 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.4 -59.8 12.69 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 117.91 -1.516 . . . . 0.0 110.457 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -42.45 -42.59 8.05 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.66 2.24 . . . . 0.0 108.885 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -44.97 95.05 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 123.876 1.798 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.63 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -60.27 -55.68 22.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 111.013 -2.812 . . . . 0.0 109.447 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.419 ' N ' HG12 ' A' ' 15' ' ' VAL . 3.2 ttp180 -65.97 -30.65 71.25 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 116.659 -2.017 . . . . 0.0 107.166 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.89 -13.5 62.21 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.171 -1.811 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -100.76 -49.85 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -59.18 -38.55 80.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.659 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -51.06 -62.96 1.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -38.05 -64.61 0.39 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.392 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.91 -60.77 2.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.14 76.02 70.19 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.672 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo . . . . . 0 N--CA 1.496 1.641 0 C-N-CA 124.62 3.547 . . . . 0.0 114.259 -175.588 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.05 -27.42 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.705 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.25 -14.86 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.578 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -91.38 -39.2 5.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.014 -2.041 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.565 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -50.61 -57.41 13.35 Favored Pre-proline 0 N--CA 1.51 2.568 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.565 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.7 Cg_endo -41.21 -41.75 4.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.303 2.002 . . . . 0.0 108.335 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.75 -34.86 62.58 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.267 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 12' ' ' TRP . 13.3 m -64.23 -48.2 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -62.81 -49.76 73.68 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -59.06 -12.45 4.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 112.029 -2.351 . . . . 0.0 110.689 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -99.64 -44.69 6.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 67.2 mmm -57.26 -26.33 60.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -58.75 -64.12 1.04 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -34.93 -60.4 0.45 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 124.319 1.012 . . . . 0.0 111.787 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.27 -64.51 0.79 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.36 69.38 68.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 124.534 1.147 . . . . 0.0 113.762 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.504 2.089 1 C-N-CA 125.421 4.081 . . . . 0.0 113.37 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 122.954 1.359 . . . . 0.0 108.251 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.12 -25.59 36.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 111.206 -2.724 . . . . 0.0 108.745 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 69.7 mt -90.5 -30.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.817 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.02 -29.7 27.77 Favored Glycine 0 N--CA 1.502 3.044 0 C-N-CA 118.047 -2.025 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.642 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.74 -59.09 13.41 Favored Pre-proline 0 N--CA 1.494 1.754 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 15.0 Cg_endo -43.19 -36.41 5.95 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.735 2.29 . . . . 0.0 109.863 174.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.5 63.77 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 123.673 1.702 . . . . 0.0 109.143 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.642 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -60.05 -48.83 86.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.603 -2.544 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -66.32 -35.86 81.45 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.93 -12.42 61.61 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.342 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -100.73 -41.76 6.77 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.107 1.432 . . . . 0.0 109.085 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.8 mtp -63.5 -39.01 93.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.692 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -53.75 -62.35 1.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 1.2 tmm_? -39.62 -65.32 0.4 Allowed 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.741 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.54 47.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -155.16 84.93 3.56 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 124.284 0.99 . . . . 0.0 109.356 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.493 1.467 0 C-N-CA 124.255 3.303 . . . . 0.0 110.568 -178.73 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.509 2.495 0 CA-C-O 124.007 1.86 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.25 -26.81 3.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 110.852 -2.885 . . . . 0.0 113.158 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.406 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 15.4 mt -94.53 -18.78 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.052 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.74 -36.22 6.53 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.407 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -47.44 -58.56 7.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 114.178 -1.011 . . . . 0.0 109.879 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.407 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 14.2 Cg_endo -41.88 -35.48 3.01 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.626 2.884 . . . . 0.0 110.539 175.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.23 58.69 Favored 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 123.886 1.803 . . . . 0.0 109.453 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.32 -51.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 110.366 -3.106 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -60.31 -37.52 80.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.8 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -71.07 -6.98 43.27 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.186 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.03 -62.77 1.2 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mmm -45.67 -35.23 3.99 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.818 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -50.75 -50.09 56.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.407 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 59.0 ttp180 -55.68 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.571 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.01 83.83 3.78 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.421 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 69.1 Cg_endo . . . . . 0 N--CA 1.497 1.699 0 C-N-CA 124.628 3.552 . . . . 0.0 113.813 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 122.573 1.177 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.76 -28.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 111.936 -2.393 . . . . 0.0 107.875 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.9 -18.93 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.407 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.452 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -95.1 -34.46 6.15 Favored Glycine 0 N--CA 1.5 2.966 0 C-N-CA 118.011 -2.042 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.578 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.36 -54.65 36.39 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.508 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -40.42 -46.24 4.4 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.268 1.979 . . . . 0.0 108.715 171.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.54 73.38 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.518 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.578 HG22 ' CE3' ' A' ' 12' ' ' TRP . 4.9 m -65.64 -51.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -55.96 -49.19 74.25 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.606 1.193 . . . . 0.0 107.829 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.54 -11.89 2.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 111.883 -2.417 . . . . 0.0 111.446 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 27.4 ttm-85 -101.3 -51.28 3.53 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.1 mtp -53.17 -45.91 68.7 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.827 -1.533 . . . . 0.0 114.102 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -46.89 -59.15 3.27 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 12.7 tpt180 -41.92 -67.13 0.28 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.346 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -36.64 -51.87 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.131 0.972 . . . . 0.0 112.857 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.43 83.41 3.69 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 124.801 1.313 . . . . 0.0 112.646 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo . . . . . 0 N--CA 1.497 1.734 0 C-N-CA 124.576 3.517 . . . . 0.0 113.089 -174.149 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.71 -31.03 28.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.242 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -94.97 -12.0 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.222 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.61 -36.3 5.64 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.069 -2.015 . . . . 0.0 110.075 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.546 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.37 -56.23 22.22 Favored Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.8 Cg_endo -40.66 -39.79 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.202 1.935 . . . . 0.0 108.894 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.53 -36.34 44.96 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.243 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 12' ' ' TRP . 22.1 m -61.99 -41.74 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -69.57 -50.46 44.52 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -61.49 -11.53 11.18 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.895 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 54.0 ttp180 -100.38 -38.81 8.28 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.984 1.373 . . . . 0.0 108.549 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.9 mmt -70.6 -39.93 73.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.318 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -59.68 -57.48 12.74 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 22.4 ttt-85 -41.48 -63.59 0.68 Allowed 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.645 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.72 64.82 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.6 78.36 10.93 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 124.454 1.096 . . . . 0.0 112.834 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 C--N 1.311 -1.436 0 C-N-CA 123.593 2.862 . . . . 0.0 113.276 -176.959 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 22.3 t -88.41 -22.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 124.368 1.043 . . . . 0.0 111.745 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.23 -14.29 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.75 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -92.31 -36.43 6.25 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 118.591 -1.766 . . . . 0.0 109.719 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -51.65 -55.9 25.75 Favored Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.515 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 18.3 Cg_endo -43.99 -24.47 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.379 2.719 . . . . 0.0 111.335 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . -90.76 -38.96 12.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.507 HG22 ' CE3' ' A' ' 12' ' ' TRP . 8.8 m -64.21 -49.4 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -61.18 -44.9 96.57 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -12.04 23.7 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.394 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 30.8 ttt85 -101.19 -47.87 4.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 124.142 1.925 . . . . 0.0 107.53 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.3 mmt -63.94 -40.21 95.93 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.153 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -56.87 -59.16 5.44 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 41.0 tpt85 -37.83 -59.21 0.84 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.265 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.31 -55.1 20.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.28 72.55 81.86 Favored Pre-proline 0 N--CA 1.493 1.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.773 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 5.0 Cg_endo . . . . . 0 N--CA 1.498 1.74 0 C-N-CA 125.105 3.87 . . . . 0.0 111.742 -173.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 122.683 1.23 . . . . 0.0 113.267 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.93 -25.28 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 112.311 -2.222 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mt -90.51 -13.31 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.564 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -97.42 -37.36 4.57 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.707 -1.711 . . . . 0.0 109.477 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.562 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -48.0 -54.6 23.05 Favored Pre-proline 0 N--CA 1.513 2.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.521 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.7 Cg_endo -39.71 -49.21 3.44 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.784 2.323 . . . . 0.0 108.823 172.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.83 -37.49 84.6 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.855 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' CE3' ' A' ' 12' ' ' TRP . 4.0 m -63.4 -52.46 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 12' ' ' TRP . 50.6 ttp180 -56.51 -49.46 74.68 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.578 1.18 . . . . 0.0 108.493 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -15.27 10.33 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 16.0 ttm105 -101.62 -41.41 6.59 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.094 0.949 . . . . 0.0 109.011 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 78.1 mtp -56.18 -41.08 74.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.268 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.6 ttt-85 -48.68 -69.31 0.12 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 16.4 ttp180 -32.46 -59.29 0.32 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 114.713 -1.131 . . . . 0.0 113.11 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.36 19.29 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.816 0.847 . . . . 0.0 112.918 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -141.32 83.05 13.91 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.311 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 N--CA 1.497 1.696 0 C-N-CA 124.36 3.373 . . . . 0.0 115.126 -175.676 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 122.845 1.307 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.52 -33.15 50.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.962 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.463 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 76.3 mt -90.89 -31.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.627 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.63 -34.52 43.83 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.258 -1.925 . . . . 0.0 110.985 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.32 -59.59 10.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.463 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 21.6 Cg_endo -47.21 -22.84 2.58 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.022 1.815 . . . . 0.0 109.891 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.48 -37.1 14.14 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.874 -1.13 . . . . 0.0 108.783 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.512 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -66.12 -47.79 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.444 -179.483 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.404 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 45.3 ttt180 -64.0 -38.94 92.92 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.48 -2.62 17.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 111.707 -2.497 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -101.0 -64.5 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 101.709 -3.441 . . . . 0.0 101.709 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 34.3 mtm -47.28 -37.66 11.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.387 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.3 -56.67 11.79 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -42.94 -64.58 0.6 Allowed 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.153 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.62 -42.84 25.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.768 1.227 . . . . 0.0 113.096 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -152.65 84.49 4.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.892 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.312 -1.359 0 C-N-CA 124.083 3.188 . . . . 0.0 111.471 174.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 120.241 0.067 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.23 -32.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 125.62 1.825 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 71.3 mt -89.24 -22.51 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -87.34 -37.87 8.01 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 116.96 -2.543 . . . . 0.0 109.643 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.544 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -47.02 -57.38 9.32 Favored Pre-proline 0 N--CA 1.513 2.682 0 O-C-N 123.816 0.362 . . . . 0.0 110.64 -179.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.2 Cg_endo -40.68 -44.48 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.67 2.246 . . . . 0.0 108.435 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.34 74.07 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.805 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.544 HG22 ' CE3' ' A' ' 12' ' ' TRP . 5.9 m -63.54 -53.78 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.6 ttp85 -59.02 -45.05 91.68 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.89 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.67 -11.16 15.45 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.039 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 38.0 ttt85 -100.86 -50.96 3.68 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.6 mmt -58.78 -39.53 81.34 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -53.42 -56.23 18.54 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 103.522 -2.769 . . . . 0.0 103.522 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 71.9 ttt180 -44.69 -65.99 0.45 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.982 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.69 -68.05 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.24 82.67 61.96 Favored Pre-proline 0 N--CA 1.493 1.697 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.194 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 N--CA 1.495 1.587 0 C-N-CA 124.56 3.507 . . . . 0.0 113.14 173.919 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 123.089 1.423 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.36 -28.37 39.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.992 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.428 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 74.1 mt -90.09 -23.85 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.862 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.77 -27.46 12.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.588 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.631 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.96 -58.35 18.27 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.514 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.8 Cg_endo -38.91 -48.22 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.773 2.315 . . . . 0.0 108.632 172.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.08 93.32 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.394 1.092 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.631 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -66.32 -46.41 87.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.527 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -67.24 -36.62 82.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -72.67 -7.45 50.47 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.057 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -101.5 -45.83 5.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 124.041 1.877 . . . . 0.0 106.731 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 42.2 mtm -66.27 -40.59 90.23 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 112.215 -2.266 . . . . 0.0 110.955 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -57.33 -51.66 68.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -48.4 -68.49 0.18 Allowed 'General case' 0 N--CA 1.513 2.723 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.18 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.49 -45.09 12.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.06 85.3 4.3 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.638 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 N--CA 1.498 1.78 0 C-N-CA 124.54 3.493 . . . . 0.0 111.906 179.601 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 123.95 1.833 . . . . 0.0 107.304 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.76 -32.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 110.877 -2.874 . . . . 0.0 113.426 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.436 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 72.0 mt -90.85 -25.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.657 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.23 -30.33 19.98 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.461 -1.828 . . . . 0.0 110.893 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.6 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.95 -59.19 12.34 Favored Pre-proline 0 N--CA 1.496 1.838 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.583 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.561 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 19.1 Cg_endo -43.95 -42.57 12.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.938 2.426 . . . . 0.0 108.959 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.31 -44.18 97.09 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 124.0 1.857 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.6 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -59.05 -55.84 20.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 110.583 -3.008 . . . . 0.0 109.687 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.492 ' N ' HG12 ' A' ' 15' ' ' VAL . 52.7 ttt180 -63.6 -34.07 77.01 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.142 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.37 -8.69 56.31 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.654 -2.066 . . . . 0.0 111.081 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -101.2 -52.48 3.25 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -57.61 -44.15 85.25 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.818 -1.537 . . . . 0.0 113.704 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -49.1 -48.05 44.7 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -58.1 -75.54 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.372 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.59 -46.33 1.77 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.556 0.693 . . . . 0.0 112.79 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.28 91.04 4.55 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.941 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 N--CA 1.497 1.715 0 C-N-CA 123.102 2.535 . . . . 0.0 109.95 173.211 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 116.48 41.76 0.72 Allowed Glycine 0 N--CA 1.5 2.951 0 O-C-N 124.056 0.847 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.06 129.75 2.82 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.59 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -79.33 49.06 0.94 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.596 0.712 . . . . 0.0 110.104 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' C ' ' H ' ' A' ' 6' ' ' LYS . 5.7 m95 -125.12 -77.22 0.59 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -66.78 1.14 1.96 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 4' ' ' TRP . 53.4 tttp -31.6 -65.31 0.14 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.846 1.341 . . . . 0.0 111.641 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -50.44 -40.98 51.93 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 122.248 1.023 . . . . 0.0 112.737 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.7 m -67.44 -43.0 82.23 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.642 1.21 . . . . 0.0 109.313 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 82.5 t -58.9 -29.61 41.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.537 -2.574 . . . . 0.0 109.171 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 82.8 mt -89.03 -20.77 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.993 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -92.59 -34.5 6.94 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 117.969 -2.062 . . . . 0.0 110.179 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.563 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.19 -56.43 20.19 Favored Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.5 Cg_endo -40.49 -40.49 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.008 2.472 . . . . 0.0 108.819 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.45 61.53 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 118.586 -1.246 . . . . 0.0 109.129 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.563 HG22 ' CE3' ' A' ' 12' ' ' TRP . 5.2 m -64.72 -52.18 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.403 ' HB2' ' CE3' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -59.58 -47.78 84.24 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -65.44 -5.0 6.53 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 117.572 -1.651 . . . . 0.0 112.216 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 18' ' ' ARG . 69.3 ttt-85 -100.63 -56.1 2.42 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mmm -54.66 -39.49 68.08 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.335 -1.302 . . . . 0.0 114.206 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -48.24 -62.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -40.54 -64.25 0.54 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.485 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.75 -46.16 20.24 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -146.44 74.82 12.62 Favored Pre-proline 0 N--CA 1.5 2.03 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.56 25.42 0.36 Allowed 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 125.036 3.824 . . . . 0.0 113.361 -169.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.16 -21.78 45.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.31 1.052 . . . . 0.0 109.439 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.642 0 O-C-N 119.483 -2.011 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.773 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -163.49 -90.24 0.08 OUTLIER Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.75 153.67 24.57 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -69.05 45.31 0.05 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.493 ' C ' ' H ' ' A' ' 6' ' ' LYS . 77.1 t-105 -161.04 -68.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 104.138 -2.542 . . . . 0.0 104.138 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.0 m -72.94 31.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.479 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 4' ' ' TRP . 57.3 pttt -100.73 -36.68 9.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.405 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 14.2 p -93.69 -75.6 0.5 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.364 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m -50.06 -19.73 0.8 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 12.5 p -64.34 -26.93 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 122.312 1.054 . . . . 0.0 108.239 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -82.2 -13.5 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.342 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.06 -28.37 10.0 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.522 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.681 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -57.95 -56.98 29.16 Favored Pre-proline 0 N--CA 1.505 2.288 0 C-N-CA 117.726 -1.589 . . . . 0.0 108.457 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.543 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.4 Cg_endo -38.79 -52.85 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 123.638 2.892 . . . . 0.0 108.187 170.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.44 -41.94 77.3 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 122.873 1.321 . . . . 0.0 112.055 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.681 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -64.39 -50.21 77.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 112.269 -2.241 . . . . 0.0 109.828 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -64.75 -34.33 78.08 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.6 -6.91 47.43 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 112.265 -2.243 . . . . 0.0 110.546 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 16.1 tpt180 -101.01 -48.69 4.35 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.419 ' SD ' ' O ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.75 -48.47 81.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.857 -1.52 . . . . 0.0 114.142 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -48.3 -50.75 28.89 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 79.1 ttt180 -54.24 -71.77 0.07 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 112.891 -1.958 . . . . 0.0 112.968 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.77 -41.18 43.63 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -148.43 81.54 7.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 114.47 -1.241 . . . . 0.0 113.574 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.35 175.96 10.68 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.463 2.775 . . . . 0.0 112.379 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.86 60.33 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 113.013 -1.903 . . . . 0.0 108.945 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.67 0 O-C-N 118.394 -2.692 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.816 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -172.26 177.67 44.8 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 105.621 -2.991 . . . . 0.0 105.621 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.73 -18.91 1.14 Allowed Glycine 0 N--CA 1.506 3.362 0 CA-C-N 117.918 0.859 . . . . 0.0 114.308 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -68.88 -18.38 64.12 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.312 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -118.55 125.21 49.35 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.6 t -156.77 4.56 0.15 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.333 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -42.35 -50.97 5.02 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -52.69 -39.66 62.16 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.932 0.872 . . . . 0.0 110.673 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.0 t -68.94 -54.12 17.14 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 123.23 1.491 . . . . 0.0 108.502 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.3 t -51.78 -37.13 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 110.811 -2.904 . . . . 0.0 112.958 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.85 -18.43 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.232 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -88.69 -37.5 7.39 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 117.57 -2.252 . . . . 0.0 109.586 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -49.82 -57.82 11.21 Favored Pre-proline 0 N--CA 1.502 2.149 0 CA-C-N 114.58 -0.81 . . . . 0.0 109.465 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -44.91 -27.42 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.154 1.903 . . . . 0.0 110.651 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.17 -32.98 17.21 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.535 HG22 ' CE3' ' A' ' 12' ' ' TRP . 10.3 m -69.95 -54.17 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.083 0.944 . . . . 0.0 110.175 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -64.81 -7.74 12.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 113.323 -1.762 . . . . 0.0 112.239 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 44.7 ttm105 -100.65 -49.36 4.21 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.5 mmm -57.54 -38.25 74.44 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.701 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -54.83 -61.83 2.05 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 73.2 ttt180 -34.88 -60.03 0.46 Allowed 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.928 1.393 . . . . 0.0 113.111 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.1 -74.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 112.692 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -116.16 72.56 4.77 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.523 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -72.16 37.07 0.34 Allowed 'Trans proline' 0 N--CA 1.503 2.057 1 C-N-CA 125.491 4.127 . . . . 0.0 113.491 -175.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.4 -16.93 60.87 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.195 0.998 . . . . 0.0 110.618 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.727 0 O-C-N 119.092 -2.255 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.83 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 98.24 -2.13 59.33 Favored Glycine 0 N--CA 1.503 3.155 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.88 -150.85 8.18 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -44.2 -36.28 2.61 Favored 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.452 ' C ' ' H ' ' A' ' 6' ' ' LYS . 77.3 m95 -59.09 -28.97 67.0 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.45 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.0 m -80.1 20.79 0.62 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 4' ' ' TRP . 22.8 pttm -28.26 -49.87 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.725 2.01 . . . . 0.0 116.027 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.2 p -44.66 -48.42 10.57 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 124.745 2.212 . . . . 0.0 111.57 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -43.01 99.81 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 110.959 -2.837 . . . . 0.0 109.347 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 t -63.14 -28.33 44.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 110.046 -3.252 . . . . 0.0 109.468 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 77.2 mt -91.23 -23.55 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.874 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.5 -36.36 9.67 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 117.879 -2.105 . . . . 0.0 109.842 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.459 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -49.47 -59.37 6.76 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.073 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.459 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 18.5 Cg_endo -43.34 -28.3 1.51 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.269 2.646 . . . . 0.0 111.604 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.29 -49.62 12.16 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 124.203 1.954 . . . . 0.0 107.204 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.53 -51.16 60.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 110.735 -2.938 . . . . 0.0 110.473 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -61.37 -37.71 84.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.94 -15.39 59.05 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 117.393 -1.723 . . . . 0.0 112.355 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.44 -54.06 2.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 75.0 mmm -54.59 -32.59 58.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.547 -2.115 . . . . 0.0 114.255 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -51.59 -62.13 1.82 Allowed 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 75.9 ttt180 -40.47 -61.57 0.9 Allowed 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.753 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.95 -62.93 1.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 25' ' ' ALA . 33.1 mt-10 -131.89 75.56 75.49 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.499 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 36.8 Cg_endo -69.98 26.22 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 124.819 3.679 . . . . 0.0 113.408 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -95.81 -23.97 16.69 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.486 0 O-C-N 119.507 -1.995 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.768 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -91.32 -21.0 36.37 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.96 -179.89 47.69 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.954 -1.117 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 3.6 mppt? -42.75 -8.38 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -61.15 -21.52 63.83 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 119.021 0.828 . . . . 0.0 110.042 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.2 m -113.41 19.52 16.87 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.016 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -39.38 -48.21 1.88 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.982 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.4 p -50.97 -46.48 61.22 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.779 1.276 . . . . 0.0 111.406 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 m -61.27 -48.14 82.79 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 124.034 1.873 . . . . 0.0 108.96 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.97 -29.92 32.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 109.653 -3.43 . . . . 0.0 112.055 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.89 -24.64 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.479 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . -91.25 -28.48 14.87 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 118.475 -1.822 . . . . 0.0 111.604 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.656 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.4 -59.15 12.91 Favored Pre-proline 0 N--CA 1.495 1.785 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.02 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.3 Cg_endo -41.9 -43.19 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.725 2.283 . . . . 0.0 109.351 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . -65.39 -39.76 92.64 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 123.068 1.413 . . . . 0.0 110.281 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.656 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -66.24 -51.88 54.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 112.614 -2.085 . . . . 0.0 108.612 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -64.99 -32.97 74.96 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -67.72 -15.64 63.74 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.168 -1.833 . . . . 0.0 110.012 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' HB2' ' NH2' ' A' ' 18' ' ' ARG . 35.8 ttm105 -100.06 -39.1 8.28 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.479 1.133 . . . . 0.0 109.004 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.4 mtp -69.14 -50.14 50.52 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.014 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -55.51 -51.01 68.43 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -49.71 -68.03 0.21 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.178 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.4 -38.19 63.19 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -149.33 83.03 6.68 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -79.03 174.98 11.44 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 124.111 3.207 . . . . 0.0 111.991 174.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.04 66.14 0.8 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.6 -1.637 . . . . 0.0 108.741 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.7 0 O-C-N 118.723 -2.486 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.748 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 70.96 -69.43 0.79 Allowed Glycine 0 N--CA 1.498 2.824 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.73 153.32 10.26 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.281 -1.927 . . . . 0.0 108.281 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 2.7 mppt? -42.3 -41.85 2.93 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -59.17 -38.09 78.92 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.664 1.221 . . . . 0.0 109.412 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.6 m -97.46 13.41 29.95 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.719 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -97.67 -40.47 8.58 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 p -91.51 -62.98 1.32 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 123.158 1.456 . . . . 0.0 113.257 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t -42.43 -41.98 3.09 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 113.084 -1.871 . . . . 0.0 112.921 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.26 -25.85 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 111.327 -2.67 . . . . 0.0 113.813 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 42.1 mt -93.0 -35.16 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 122.566 1.174 . . . . 0.0 110.042 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -38.74 66.72 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 118.309 -1.9 . . . . 0.0 110.233 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.532 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -54.61 -61.44 5.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 117.629 -1.628 . . . . 0.0 112.902 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 25.7 Cg_endo -47.98 -20.6 2.17 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.659 1.573 . . . . 0.0 110.337 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 -32.44 16.64 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 123.843 1.782 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -73.41 -49.25 38.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 112.063 -2.335 . . . . 0.0 108.637 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -61.92 -37.46 84.76 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 14.1 tm-20 -63.94 -17.37 63.18 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 110.963 -2.835 . . . . 0.0 110.664 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 37.9 ttm180 -101.2 -41.91 6.54 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.503 1.62 . . . . 0.0 109.669 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 63.4 mtp -63.66 -34.8 78.66 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.682 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -56.36 -63.59 1.14 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 12.2 tpt180 -36.68 -61.57 0.53 Allowed 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.461 -1.699 . . . . 0.0 112.504 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.85 -60.77 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 25' ' ' ALA . 34.6 mt-10 -137.75 72.87 48.34 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.107 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.65 15.62 0.14 Allowed 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 125.003 3.802 . . . . 0.0 113.852 -170.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -105.39 -13.85 15.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 O-C-N 118.944 -2.347 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.652 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 169.06 -170.42 42.47 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.48 -91.42 0.11 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 105.737 -2.945 . . . . 0.0 105.737 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.28 67.82 2.58 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -60.04 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.768 1.27 . . . . 0.0 109.664 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m -114.45 78.2 1.13 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 112.88 -1.963 . . . . 0.0 107.07 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -31.74 -62.21 0.21 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 124.067 0.854 . . . . 0.0 113.076 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.83 -39.55 25.9 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.84 0.829 . . . . 0.0 112.367 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.4 t -66.74 -47.19 73.05 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 123.897 1.808 . . . . 0.0 106.733 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.03 -28.32 40.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 110.841 -2.891 . . . . 0.0 111.385 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 74.4 mt -93.06 -21.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.8 -29.99 10.08 Favored Glycine 0 N--CA 1.504 3.215 0 C-N-CA 118.688 -1.72 . . . . 0.0 110.629 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.688 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -53.59 -57.12 18.63 Favored Pre-proline 0 N--CA 1.496 1.855 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.115 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.0 Cg_endo -41.03 -43.0 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 123.475 2.784 . . . . 0.0 110.097 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.22 94.5 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 123.494 1.616 . . . . 0.0 108.276 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.688 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -62.01 -48.18 89.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 111.382 -2.645 . . . . 0.0 110.283 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 ttp85 -64.27 -34.77 78.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -75.33 -6.18 48.61 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.125 -2.307 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 14.3 ttm180 -100.71 -40.02 7.56 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 123.867 1.794 . . . . 0.0 107.877 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 70.9 mtp -65.82 -46.64 77.84 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.572 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -50.13 -59.23 4.13 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -43.67 -63.31 0.87 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.486 178.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.18 -43.71 42.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -153.28 81.58 5.01 Favored Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.725 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.38 53.65 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 124.58 3.52 . . . . 0.0 115.29 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.99 -68.64 0.79 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 118.827 -2.421 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.763 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -114.34 141.96 17.28 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -167.8 168.48 40.71 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 107.513 -2.235 . . . . 0.0 107.513 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -74.54 50.07 0.41 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 118.116 0.958 . . . . 0.0 113.512 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -129.33 -79.96 0.56 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 m -74.98 11.73 1.03 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.781 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -43.93 -45.42 7.64 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 122.084 0.945 . . . . 0.0 110.022 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -53.69 -43.41 68.9 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.095 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.8 p -76.63 -44.22 35.03 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.524 -1.67 . . . . 0.0 109.217 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.7 t -48.33 -34.78 5.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.312 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 72.6 mt -91.25 -22.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.039 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.3 -21.04 25.87 Favored Glycine 0 N--CA 1.505 3.278 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.462 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.55 -57.15 17.95 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 10.8 Cg_endo -40.75 -43.49 4.51 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.641 2.227 . . . . 0.0 109.281 172.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.74 72.42 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 123.748 1.737 . . . . 0.0 108.902 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 12' ' ' TRP . 6.3 t -56.84 -60.45 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 110.117 -3.219 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -61.35 -29.01 69.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 116.578 -2.049 . . . . 0.0 109.777 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.93 -12.66 60.41 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 115.792 -2.363 . . . . 0.0 111.187 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HB3' ' SD ' ' A' ' 19' ' ' MET . 44.7 ttm180 -101.56 -47.06 4.77 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 123.716 1.722 . . . . 0.0 108.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -62.26 -40.24 95.54 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.932 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -54.32 -63.61 1.1 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -36.19 -62.47 0.44 Allowed 'General case' 0 N--CA 1.512 2.652 0 O-C-N 123.765 0.666 . . . . 0.0 112.052 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.06 -39.21 41.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -155.11 83.36 3.82 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -74.26 58.02 4.23 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.7 2.933 . . . . 0.0 108.496 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -174.64 -29.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.581 -1.645 . . . . 0.0 107.84 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.453 0 O-C-N 118.776 -2.452 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -39.98 -40.56 1.74 Allowed Glycine 0 N--CA 1.505 3.297 0 N-CA-C 114.104 0.402 . . . . 0.0 114.104 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.34 -36.23 45.34 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.546 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -94.56 24.67 4.43 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.247 1.022 . . . . 0.0 111.522 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -132.35 -62.48 0.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 m -75.64 62.53 1.47 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.204 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -100.04 -92.75 0.28 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.344 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -45.47 -30.27 1.36 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.232 0.539 . . . . 0.0 111.5 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 p -60.95 -47.22 87.42 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 124.063 1.887 . . . . 0.0 108.271 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.17 -18.21 23.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 110.374 -3.103 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 35.6 mm -91.76 -36.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.594 1.187 . . . . 0.0 110.731 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.19 -26.92 42.15 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.904 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.63 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -60.4 -59.8 12.69 Favored Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 117.91 -1.516 . . . . 0.0 110.457 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -42.45 -42.59 8.05 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.66 2.24 . . . . 0.0 108.885 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.52 -44.97 95.05 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 123.876 1.798 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.63 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.5 OUTLIER -60.27 -55.68 22.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 111.013 -2.812 . . . . 0.0 109.447 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' N ' HG12 ' A' ' 15' ' ' VAL . 3.2 ttp180 -65.97 -30.65 71.25 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 116.659 -2.017 . . . . 0.0 107.166 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.89 -13.5 62.21 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.171 -1.811 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -100.76 -49.85 4.04 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -59.18 -38.55 80.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.659 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -51.06 -62.96 1.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -38.05 -64.61 0.39 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 113.285 -1.78 . . . . 0.0 112.392 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.91 -60.77 2.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -133.14 76.02 70.19 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.672 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -72.45 36.22 0.34 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 124.62 3.547 . . . . 0.0 114.259 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.16 44.95 0.6 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.7 1.238 . . . . 0.0 108.355 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.703 0 O-C-N 118.603 -2.56 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.713 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 75.68 -41.84 1.47 Allowed Glycine 0 N--CA 1.506 3.305 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 44.9 -93.46 0.01 OUTLIER Glycine 0 N--CA 1.501 2.975 0 CA-C-O 119.866 -0.408 . . . . 0.0 112.985 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.78 -40.3 92.06 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.549 0.69 . . . . 0.0 109.932 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -72.58 -31.57 65.33 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.833 -1.147 . . . . 0.0 108.046 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.4 m -78.29 47.22 0.67 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -100.58 -54.48 2.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.623 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 p -90.97 -66.68 0.91 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.685 1.231 . . . . 0.0 113.789 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -50.26 -26.8 5.12 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.647 -1.615 . . . . 0.0 114.55 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.05 -27.42 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.705 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.25 -14.86 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.578 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -91.38 -39.2 5.71 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.014 -2.041 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.565 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -50.61 -57.41 13.35 Favored Pre-proline 0 N--CA 1.51 2.568 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.565 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 13.7 Cg_endo -41.21 -41.75 4.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.303 2.002 . . . . 0.0 108.335 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.75 -34.86 62.58 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.267 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 12' ' ' TRP . 13.3 m -64.23 -48.2 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -62.81 -49.76 73.68 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -59.06 -12.45 4.82 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 112.029 -2.351 . . . . 0.0 110.689 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -99.64 -44.69 6.04 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 67.2 mmm -57.26 -26.33 60.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -58.75 -64.12 1.04 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -34.93 -60.4 0.45 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 124.319 1.012 . . . . 0.0 111.787 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.27 -64.51 0.79 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 25' ' ' ALA . 46.6 mt-10 -126.36 69.38 68.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 124.534 1.147 . . . . 0.0 113.762 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.81 11.9 0.28 Allowed 'Trans proline' 0 N--CA 1.504 2.089 1 C-N-CA 125.421 4.081 . . . . 0.0 113.37 -169.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -94.83 -21.12 18.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.55 0 O-C-N 119.531 -1.98 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -69.62 104.86 1.38 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.02 -101.48 0.52 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.649 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -75.32 49.78 0.48 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.363 0.601 . . . . 0.0 110.684 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -175.74 125.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.0 m -154.85 62.73 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 24.0 tptm -34.15 -63.11 0.29 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.415 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 m -48.87 -37.75 20.49 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.512 0.672 . . . . 0.0 111.745 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m -67.54 -42.49 82.6 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.954 1.359 . . . . 0.0 108.251 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 6' ' ' LYS . 99.9 t -61.12 -25.59 36.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 CA-C-N 111.206 -2.724 . . . . 0.0 108.745 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 69.7 mt -90.5 -30.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.817 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.02 -29.7 27.77 Favored Glycine 0 N--CA 1.502 3.044 0 C-N-CA 118.047 -2.025 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.642 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.74 -59.09 13.41 Favored Pre-proline 0 N--CA 1.494 1.754 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.316 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 15.0 Cg_endo -43.19 -36.41 5.95 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.735 2.29 . . . . 0.0 109.863 174.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -44.5 63.77 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 123.673 1.702 . . . . 0.0 109.143 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.642 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -60.05 -48.83 86.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 111.603 -2.544 . . . . 0.0 110.308 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -66.32 -35.86 81.45 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.93 -12.42 61.61 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.297 -2.229 . . . . 0.0 110.342 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -100.73 -41.76 6.77 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.107 1.432 . . . . 0.0 109.085 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.8 mtp -63.5 -39.01 93.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.692 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -53.75 -62.35 1.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 102.526 -3.139 . . . . 0.0 102.526 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 1.2 tmm_? -39.62 -65.32 0.4 Allowed 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.741 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.54 47.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -155.16 84.93 3.56 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 124.284 0.99 . . . . 0.0 109.356 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.56 69.91 2.05 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 124.255 3.303 . . . . 0.0 110.568 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -176.2 -36.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 110.89 -2.868 . . . . 0.0 106.156 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.406 0 O-C-N 119.09 -2.256 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.767 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 143.85 -143.54 12.39 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 107.971 -2.051 . . . . 0.0 107.971 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -45.85 1.89 Allowed Glycine 0 N--CA 1.501 2.967 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.914 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -62.97 54.45 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -101.06 -5.1 26.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.62 -0.675 . . . . 0.0 111.733 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t -138.53 79.78 1.75 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.936 1.35 . . . . 0.0 111.703 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.458 ' H ' ' HD3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -100.09 -36.61 9.28 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.235 -1.802 . . . . 0.0 107.079 179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.8 t -105.91 -43.13 4.95 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.651 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -47.29 -47.12 25.31 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 124.007 1.86 . . . . 0.0 109.599 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.25 -26.81 3.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 110.852 -2.885 . . . . 0.0 113.158 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.406 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 15.4 mt -94.53 -18.78 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.052 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.74 -36.22 6.53 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.407 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -47.44 -58.56 7.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 114.178 -1.011 . . . . 0.0 109.879 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 14.2 Cg_endo -41.88 -35.48 3.01 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.626 2.884 . . . . 0.0 110.539 175.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.23 58.69 Favored 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 123.886 1.803 . . . . 0.0 109.453 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.32 -51.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 110.366 -3.106 . . . . 0.0 110.966 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -60.31 -37.52 80.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.8 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -71.07 -6.98 43.27 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.97 -1.923 . . . . 0.0 112.186 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.03 -62.77 1.2 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mmm -45.67 -35.23 3.99 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.818 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -50.75 -50.09 56.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 59.0 ttp180 -55.68 -75.93 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.571 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.01 83.83 3.78 Favored Pre-proline 0 N--CA 1.497 1.883 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.421 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 69.1 Cg_endo -70.9 62.9 2.44 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 124.628 3.552 . . . . 0.0 113.813 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.68 -0.39 12.98 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 112.898 -1.955 . . . . 0.0 108.784 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.542 0 O-C-N 118.943 -2.348 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.69 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 112.19 -115.45 3.81 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.22 127.22 2.91 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -41.51 -30.03 0.19 Allowed 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 47.1 t-105 -59.65 -26.67 65.71 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.4 m -121.86 -2.36 9.28 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -35.73 -63.24 0.37 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 t -44.99 -43.21 8.94 Favored 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 m -74.0 -35.91 64.46 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.308 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.76 -28.07 42.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 111.936 -2.393 . . . . 0.0 107.875 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.9 -18.93 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.407 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -95.1 -34.46 6.15 Favored Glycine 0 N--CA 1.5 2.966 0 C-N-CA 118.011 -2.042 . . . . 0.0 110.943 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.578 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.36 -54.65 36.39 Favored Pre-proline 0 N--CA 1.51 2.527 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.508 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.1 Cg_endo -40.42 -46.24 4.4 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 122.268 1.979 . . . . 0.0 108.715 171.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.54 73.38 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.518 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.578 HG22 ' CE3' ' A' ' 12' ' ' TRP . 4.9 m -65.64 -51.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -55.96 -49.19 74.25 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.606 1.193 . . . . 0.0 107.829 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.54 -11.89 2.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 111.883 -2.417 . . . . 0.0 111.446 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 27.4 ttm-85 -101.3 -51.28 3.53 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.1 mtp -53.17 -45.91 68.7 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.827 -1.533 . . . . 0.0 114.102 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -46.89 -59.15 3.27 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 12.7 tpt180 -41.92 -67.13 0.28 Allowed 'General case' 0 N--CA 1.514 2.741 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.346 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -36.64 -51.87 0.87 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.131 0.972 . . . . 0.0 112.857 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.43 83.41 3.69 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 124.801 1.313 . . . . 0.0 112.646 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -74.28 38.45 0.49 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 124.576 3.517 . . . . 0.0 113.089 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.3 39.39 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.722 0 O-C-N 118.964 -2.335 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.754 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -131.38 141.82 13.15 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 107.281 -2.328 . . . . 0.0 107.281 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.84 -79.66 0.19 Allowed Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.83 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -40.97 -30.29 0.13 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -58.65 -33.05 69.66 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.072 0.939 . . . . 0.0 109.509 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 m -117.4 28.11 8.67 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.719 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -100.3 -40.58 7.45 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 118.417 -1.313 . . . . 0.0 110.129 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.9 p -90.3 -68.68 0.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.567 1.175 . . . . 0.0 113.024 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 m -42.58 -40.79 2.81 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.382 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.71 -31.03 28.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.242 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -94.97 -12.0 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.222 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.61 -36.3 5.64 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.069 -2.015 . . . . 0.0 110.075 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.546 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.37 -56.23 22.22 Favored Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 12.8 Cg_endo -40.66 -39.79 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.202 1.935 . . . . 0.0 108.894 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.53 -36.34 44.96 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.243 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 12' ' ' TRP . 22.1 m -61.99 -41.74 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -69.57 -50.46 44.52 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -61.49 -11.53 11.18 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.895 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 54.0 ttp180 -100.38 -38.81 8.28 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.984 1.373 . . . . 0.0 108.549 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.9 mmt -70.6 -39.93 73.51 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.318 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -59.68 -57.48 12.74 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 100.38 -3.933 . . . . 0.0 100.38 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 22.4 ttt-85 -41.48 -63.59 0.68 Allowed 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.645 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.72 64.82 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.6 78.36 10.93 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 124.454 1.096 . . . . 0.0 112.834 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.82 4.53 3.06 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 123.593 2.862 . . . . 0.0 113.276 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.77 -28.62 8.33 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.52 0 O-C-N 118.907 -2.371 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.858 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 165.7 -165.93 38.25 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' TRP . . . 146.12 -145.93 15.47 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 118.67 -1.728 . . . . 0.0 110.793 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.75 -8.79 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' GLY . 93.5 m95 -87.36 -32.93 19.35 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.946 0.879 . . . . 0.0 110.217 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m -62.41 13.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 11.5 mmpt? -42.13 -43.95 3.48 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.3 t -50.36 -18.36 0.62 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.727 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 t -112.56 -15.0 13.13 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.091 0.869 . . . . 0.0 109.801 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 22.3 t -88.41 -22.52 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 124.368 1.043 . . . . 0.0 111.745 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.5 mt -87.23 -14.29 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.75 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -92.31 -36.43 6.25 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 118.591 -1.766 . . . . 0.0 109.719 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -51.65 -55.9 25.75 Favored Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.515 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 18.3 Cg_endo -43.99 -24.47 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.379 2.719 . . . . 0.0 111.335 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . -90.76 -38.96 12.68 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG22 ' CE3' ' A' ' 12' ' ' TRP . 8.8 m -64.21 -49.4 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -61.18 -44.9 96.57 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -12.04 23.7 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.394 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 30.8 ttt85 -101.19 -47.87 4.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 124.142 1.925 . . . . 0.0 107.53 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.3 mmt -63.94 -40.21 95.93 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.153 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -56.87 -59.16 5.44 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 41.0 tpt85 -37.83 -59.21 0.84 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.265 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.31 -55.1 20.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.28 72.55 81.86 Favored Pre-proline 0 N--CA 1.493 1.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.773 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 5.0 Cg_endo -77.56 46.92 2.14 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 125.105 3.87 . . . . 0.0 111.742 -173.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.11 -26.56 66.76 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.223 1.011 . . . . 0.0 111.775 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.682 0 O-C-N 118.397 -2.689 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.831 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 161.64 -165.93 35.84 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 106.712 -2.555 . . . . 0.0 106.712 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 137.86 -155.44 23.21 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.0 -53.85 3.05 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -159.35 -87.8 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.9 m -75.06 61.74 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -100.6 -61.97 1.3 Allowed 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 t -97.08 -53.51 3.48 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.927 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -50.75 -33.76 24.45 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.683 1.23 . . . . 0.0 113.267 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.93 -25.28 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-N 112.311 -2.222 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mt -90.51 -13.31 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.564 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -97.42 -37.36 4.57 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 118.707 -1.711 . . . . 0.0 109.477 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.562 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -48.0 -54.6 23.05 Favored Pre-proline 0 N--CA 1.513 2.683 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.7 Cg_endo -39.71 -49.21 3.44 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.784 2.323 . . . . 0.0 108.823 172.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.83 -37.49 84.6 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 118.485 -1.286 . . . . 0.0 110.855 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' CE3' ' A' ' 12' ' ' TRP . 4.0 m -63.4 -52.46 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 12' ' ' TRP . 50.6 ttp180 -56.51 -49.46 74.68 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.578 1.18 . . . . 0.0 108.493 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -15.27 10.33 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 16.0 ttm105 -101.62 -41.41 6.59 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 122.094 0.949 . . . . 0.0 109.011 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 78.1 mtp -56.18 -41.08 74.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.268 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.6 ttt-85 -48.68 -69.31 0.12 Allowed 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 16.4 ttp180 -32.46 -59.29 0.32 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 114.713 -1.131 . . . . 0.0 113.11 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.36 19.29 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.816 0.847 . . . . 0.0 112.918 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -141.32 83.05 13.91 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.311 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.31 63.2 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 124.36 3.373 . . . . 0.0 115.126 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.16 -31.54 10.54 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.338 -1.756 . . . . 0.0 109.554 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.52 0 O-C-N 118.65 -2.531 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.821 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 151.41 -86.58 0.14 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.29 -62.42 3.74 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 5' ' ' SER . 64.6 mttm -39.1 -68.8 0.15 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.887 0.851 . . . . 0.0 112.341 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 20.0 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.185 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 3' ' ' LYS . 70.6 m -147.25 11.69 1.03 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.42 -53.9 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.25 0.969 . . . . 0.0 111.907 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 p -52.76 -42.31 64.86 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.317 1.056 . . . . 0.0 111.711 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 m -68.47 -40.35 81.04 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.749 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.52 -33.15 50.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 111.662 -2.517 . . . . 0.0 109.962 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.463 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 76.3 mt -90.89 -31.36 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.627 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.63 -34.52 43.83 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 118.258 -1.925 . . . . 0.0 110.985 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.32 -59.59 10.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.463 ' HG2' ' O ' ' A' ' 10' ' ' ILE . 21.6 Cg_endo -47.21 -22.84 2.58 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.022 1.815 . . . . 0.0 109.891 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.48 -37.1 14.14 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.874 -1.13 . . . . 0.0 108.783 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.512 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -66.12 -47.79 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 113.505 -1.679 . . . . 0.0 110.444 -179.483 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.404 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 45.3 ttt180 -64.0 -38.94 92.92 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -71.48 -2.62 17.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 111.707 -2.497 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -101.0 -64.5 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 101.709 -3.441 . . . . 0.0 101.709 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 34.3 mtm -47.28 -37.66 11.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.387 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -51.3 -56.67 11.79 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -42.94 -64.58 0.6 Allowed 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.153 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.62 -42.84 25.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.768 1.227 . . . . 0.0 113.096 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -152.65 84.49 4.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.892 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -179.42 4.68 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 124.083 3.188 . . . . 0.0 111.471 174.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.13 63.22 0.69 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.581 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.6 0 O-C-N 118.66 -2.525 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.806 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 76.21 -66.48 2.56 Favored Glycine 0 N--CA 1.499 2.874 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.46 133.45 2.58 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -40.48 -50.45 2.91 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -81.69 6.81 14.13 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -113.8 61.14 0.66 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -100.14 -78.09 0.52 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.05 -43.36 40.75 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.889 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -72.84 -16.81 61.59 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 117.655 -1.618 . . . . 0.0 111.105 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.23 -32.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 125.62 1.825 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 71.3 mt -89.24 -22.51 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.149 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -87.34 -37.87 8.01 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 116.96 -2.543 . . . . 0.0 109.643 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.544 ' CE3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -47.02 -57.38 9.32 Favored Pre-proline 0 N--CA 1.513 2.682 0 O-C-N 123.816 0.362 . . . . 0.0 110.64 -179.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 11.2 Cg_endo -40.68 -44.48 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.67 2.246 . . . . 0.0 108.435 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.34 74.07 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.805 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.544 HG22 ' CE3' ' A' ' 12' ' ' TRP . 5.9 m -63.54 -53.78 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.6 ttp85 -59.02 -45.05 91.68 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.89 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.67 -11.16 15.45 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.039 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 38.0 ttt85 -100.86 -50.96 3.68 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 29.6 mmt -58.78 -39.53 81.34 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -53.42 -56.23 18.54 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 103.522 -2.769 . . . . 0.0 103.522 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 71.9 ttt180 -44.69 -65.99 0.45 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.982 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.69 -68.05 0.23 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.24 82.67 61.96 Favored Pre-proline 0 N--CA 1.493 1.697 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.194 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.96 -168.05 0.51 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 124.56 3.507 . . . . 0.0 113.14 173.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.4 55.32 0.11 Allowed 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.269 1.033 . . . . 0.0 113.429 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.742 0 O-C-N 117.856 -3.028 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.799 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . -152.98 -129.22 1.38 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.77 163.88 30.56 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -19.24 -81.89 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.443 ' C ' ' H ' ' A' ' 6' ' ' LYS . 9.5 t-105 -167.22 -80.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.62 31.55 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.325 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 4' ' ' TRP . 41.5 tttm -41.14 -57.88 1.94 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 123.167 0.587 . . . . 0.0 111.823 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -55.64 -36.16 66.72 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.833 0.825 . . . . 0.0 110.507 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -65.98 -44.63 84.36 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 123.089 1.423 . . . . 0.0 108.355 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.1 t -59.36 -28.37 39.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 111.766 -2.47 . . . . 0.0 110.992 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.428 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 74.1 mt -90.09 -23.85 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.862 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.77 -27.46 12.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 118.842 -1.647 . . . . 0.0 111.588 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.631 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -56.96 -58.35 18.27 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.514 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 9.8 Cg_endo -38.91 -48.22 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.773 2.315 . . . . 0.0 108.632 172.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.08 93.32 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.394 1.092 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.631 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.4 OUTLIER -66.32 -46.41 87.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.527 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -67.24 -36.62 82.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -72.67 -7.45 50.47 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.057 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -101.5 -45.83 5.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 124.041 1.877 . . . . 0.0 106.731 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 42.2 mtm -66.27 -40.59 90.23 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 112.215 -2.266 . . . . 0.0 110.955 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -57.33 -51.66 68.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -48.4 -68.49 0.18 Allowed 'General case' 0 N--CA 1.513 2.723 0 C-N-CA 118.701 -1.2 . . . . 0.0 112.18 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.49 -45.09 12.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.06 85.3 4.3 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.638 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.47 66.9 1.12 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 124.54 3.493 . . . . 0.0 111.906 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -172.33 -39.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 111.549 -2.569 . . . . 0.0 106.015 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.446 0 O-C-N 119.265 -2.147 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.831 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' B GLY . . . . . . . . . . . . . . . 169.63 -164.07 37.57 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.14 147.24 15.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 104.592 -3.403 . . . . 0.0 104.592 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -70.48 62.45 0.25 Allowed 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -85.81 -38.95 17.61 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.392 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.5 m -72.51 35.69 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.512 ' HG3' ' H ' ' A' ' 7' ' ' SER . 36.8 pttt -38.39 -57.89 1.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.512 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 1.1 m -51.23 -34.85 34.04 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.495 0.664 . . . . 0.0 111.585 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 t -70.77 -47.44 59.57 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 123.95 1.833 . . . . 0.0 107.304 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.76 -32.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 110.877 -2.874 . . . . 0.0 113.426 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' O ' ' HG2' ' A' ' 13' ' ' PRO . 72.0 mt -90.85 -25.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.657 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.23 -30.33 19.98 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.461 -1.828 . . . . 0.0 110.893 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.6 ' CE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.95 -59.19 12.34 Favored Pre-proline 0 N--CA 1.496 1.838 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.583 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.561 ' CD ' ' HB3' ' A' ' 12' ' ' TRP . 19.1 Cg_endo -43.95 -42.57 12.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.938 2.426 . . . . 0.0 108.959 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.31 -44.18 97.09 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 124.0 1.857 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.6 HG12 ' CE3' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -59.05 -55.84 20.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 110.583 -3.008 . . . . 0.0 109.687 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.492 ' N ' HG12 ' A' ' 15' ' ' VAL . 52.7 ttt180 -63.6 -34.07 77.01 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.142 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.37 -8.69 56.31 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 112.654 -2.066 . . . . 0.0 111.081 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -101.2 -52.48 3.25 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -57.61 -44.15 85.25 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.818 -1.537 . . . . 0.0 113.704 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -49.1 -48.05 44.7 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -58.1 -75.54 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.372 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.59 -46.33 1.77 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.556 0.693 . . . . 0.0 112.79 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.28 91.04 4.55 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.941 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.22 66.3 3.49 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 123.102 2.535 . . . . 0.0 109.95 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 179.81 -32.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 110.95 -2.841 . . . . 0.0 106.32 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.423 0 O-C-N 119.298 -2.126 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_